RAB7A: A Comprehensive Review of Ras-related Protein Rab-7a

Introduction

RAB7A (also known as RAB7) encodes the Ras-related protein Rab-7a, a small GTPase belonging to the Rab family within the larger Ras superfamily. In humans, the RAB7A gene (HGNC:9788) produces a 23 kDa protein (UniProt: P51149) that functions as a master regulator of late endocytic trafficking, lysosomal biogenesis, and autophagy [guerra-2016-multiple-roles-summary]. The protein possesses intrinsic GTPase activity (EC 3.6.5.2) and contains characteristic structural domains including a P-loop NTPase domain, small GTP-binding domain (IPR005225), and a Ras domain (PF00071) that are essential for its molecular function [guerra-2016-multiple-roles-summary].

Rab7a operates as a molecular switch, cycling between an active GTP-bound state that interacts with downstream effector proteins and an inactive GDP-bound state that cannot engage effectors [khori-2018-rab7-regulation-summary]. This nucleotide-dependent conformational change enables Rab7a to coordinate multiple cellular processes including endosomal maturation, autophagosome-lysosome fusion, retrograde transport to the trans-Golgi network, and neurotrophin signaling in neurons [hyttinen-2013-maturation-review-summary]. Mutations in RAB7A cause Charcot-Marie-Tooth disease type 2B (CMT2B), a hereditary peripheral neuropathy, underscoring the protein's critical importance in neuronal function [romano-2021-cmt2b-summary].

Molecular Function and GTPase Activity

GTP-GDP Cycling Mechanism

Like other members of the Ras superfamily, Rab7a exhibits high affinity for guanine nucleotides GTP and GDP (Kd in the nanomolar range) but possesses weak intrinsic GTPase activity [khori-2018-rab7-regulation-summary]. The protein's catalytic activity depends on a conserved DXXGQ motif in the switch-II region, where the glutamine residue participates in coordinating the water molecule that hydrolyzes GTP. Mutations of this glutamine to leucine (Q67L) impede GTP hydrolysis, rendering the protein GTP-locked and constitutively active [guerra-2016-multiple-roles-summary].

Structural Biology of Rab7a

High-resolution crystal structures of Rab7a in both GTP-bound and GDP-bound states have been determined (PDB: 1T91, 1VG8, 1VG1, 3LAW), providing detailed insights into the conformational changes underlying its molecular switch function. The Switch I and Switch II regions undergo large nucleotide-dependent conformational transitions that control effector binding [guerra-2016-multiple-roles-summary]. Rab7a interacts with RILP specifically via two distinct areas: the first involves the switch and interswitch regions, while the second consists of RabSF1 and RabSF4 [guerra-2016-multiple-roles-summary]. Remarkably, upon binding to the RILP RBD, drastic remodeling of Rab7a occurs: the C-terminal helix and part of the hypervariable domain (HVD) refold into an additional β strand that interacts directly with the effector [guerra-2016-multiple-roles-summary].

Crystal structures of the CMT2B-associated L129F mutant (PDB: 3LAW) at 2.8 Å resolution reveal normal conformations of the effector binding regions and catalytic site, but alterations to the nucleotide binding pocket that are predicted to affect GTP binding dynamics, providing structural insight into disease pathogenesis [romano-2021-cmt2b-summary].

The GTPase cycle of Rab7a is controlled by two classes of regulatory proteins. Guanine nucleotide exchange factors (GEFs) stimulate GDP dissociation to allow replacement by GTP, thereby activating Rab7a. Conversely, GTPase-activating proteins (GAPs) accelerate the intrinsic GTP hydrolysis rate, inactivating the protein [khori-2018-rab7-regulation-summary]. The sole known GEF for mammalian Rab7a is the Mon1-Ccz1 heterodimeric complex, which is structurally distinct from the DENN domain-containing GEFs that activate most other Rab proteins [cai-2022-mon1-ccz1-structure-abstract]. Several GAPs regulate Rab7a activity, including Armus/TBC1D2A, TBC1D5, and TBC1D15, each containing a TBC (Tre-2/Bub2/Cdc16) domain that catalyzes GTP hydrolysis via a "dual-finger mechanism" involving a conserved glutamine that activates the hydrolyzing water molecule and an arginine that stabilizes the transition state [khori-2018-rab7-regulation-summary]. This mechanism can accelerate GTP hydrolysis by up to 10^5-fold over the intrinsic rate.

Prenylation and Membrane Association

Rab7a requires post-translational modification by geranylgeranylation for proper membrane localization and function. The protein is irreversibly prenylated on two C-terminal cysteines (C205 and C207) shortly after translation [guerra-2016-multiple-roles-summary]. This dual prenylation is catalyzed by Rab geranylgeranyl transferase (RabGGT), which requires Rab escort protein (REP) as an adaptor to present newly synthesized Rab7a to the transferase. Structural studies have revealed that transfer of the first geranylgeranyl group proceeds approximately four times faster than transfer of the second group [guerra-2016-multiple-roles-summary].

Dual geranylgeranylation is essential for proper membrane targeting; mono-geranylgeranylation provides sufficient hydrophobicity for membrane association but cannot substitute for double modification in achieving correct organelle localization [guerra-2016-multiple-roles-summary]. In the cytoplasm, GDP-bound Rab7a associates with GDP Dissociation Inhibitor (GDI), which sequesters the prenylated protein in a soluble state. Upon displacement from GDI, Rab7a is recruited to target membranes where it undergoes GEF-mediated activation [khori-2018-rab7-regulation-summary].

Subcellular Localization

Rab7a predominantly localizes to the limiting membranes of late endosomes and lysosomes, where it performs its primary functions in endocytic trafficking [bucci-2000-lysosome-biogenesis-abstract]. The protein concentrates in the perinuclear region where late endosomal and lysosomal clusters assemble, reflecting its role in organizing these compartments [guerra-2016-multiple-roles-summary]. However, Rab7a is not restricted to the late endocytic pathway; the protein has also been detected on autophagosomes, the endoplasmic reticulum, trans-Golgi network, and mitochondrial membranes [seiwert-2022-retromer-mitophagy-abstract].

The dynamic distribution of Rab7a across multiple compartments is controlled by the balance of GEF and GAP activities at different membrane locations. Retromer and TBC1D5 maintain pools of inactive, mobile Rab7a on endomembranes, enabling the protein to be rapidly recruited and activated at sites requiring its function [seiwert-2022-retromer-mitophagy-abstract]. In the absence of this regulatory system, hyperactivated Rab7a accumulates on lysosomes and becomes depleted from other compartments, disrupting non-lysosomal functions such as mitophagy [seiwert-2022-retromer-mitophagy-abstract].

Rab5-to-Rab7 Conversion and Endosomal Maturation

The Rab Conversion Mechanism

A fundamental function of Rab7a is coordinating the conversion of early endosomes to late endosomes, a process known as Rab conversion [rink-2005-rab-conversion-abstract]. Using advanced live-cell imaging combined with image analysis algorithms, Rink and colleagues demonstrated that within minutes after early endosome formation, Rab5 is replaced by Rab7 in a highly coordinated process that is completed within approximately four minutes [rink-2005-rab-conversion-abstract].

The molecular switch controlling this conversion is the SAND-1/Mon1 protein, which serves a dual function [poteryaev-2010-switch-abstract]. First, Mon1 interrupts the positive feedback loop maintaining Rab5 activation by displacing RABX-5 (the Rab5 GEF) from endosomal membranes. Second, Mon1 recruits Rab7 by forming a complex with Ccz1 that functions as the Rab7 GEF [poteryaev-2010-switch-abstract]. The Mon1-Ccz1 complex thus acts as a master switch controlling the temporal sequence of Rab5 displacement and Rab7 recruitment.

GEF Structure and Activation Mechanism

Cryo-electron microscopy structures of the Mon1-Ccz1 complex have revealed its unique architecture [cai-2022-mon1-ccz1-structure-abstract]. Mon1 and Ccz1 form a pseudo-twofold symmetrical heterodimer, with the three Longin domains of each subunit arranged triangularly to provide a stable scaffold for the catalytic center. The complex activates Rab7 by inserting a lysine residue from Rab7 into the nucleotide-binding pocket, destabilizing magnesium coordination essential for GDP binding [khori-2018-rab7-regulation-summary]. A positively charged patch on the Longin domains 2/3 of Mon1 serves as a phosphatidylinositol-3-phosphate (PI3P) binding site, targeting the GEF to endosomal membranes [cai-2022-mon1-ccz1-structure-abstract].

The intrinsically disordered N-terminal domain of Mon1 autoinhibits Rab5-dependent GEF activity, providing an additional regulatory layer [cai-2022-mon1-ccz1-structure-abstract]. The metazoan complex contains a third subunit, Bulli/RMC1, whose function remains unclear but is not required for Rab5-dependent Rab7 activation [khori-2018-rab7-regulation-summary].

Effector Proteins and Downstream Functions

RILP and Minus-End Microtubule Transport

Rab-interacting lysosomal protein (RILP) is a key effector that mediates minus-end directed transport of late endosomes and lysosomes along microtubules [cantalupo-2001-rilp-abstract]. The C-terminal region of RILP (amino acids 244-308) forms a coiled-coil homodimer that interacts with two GTP-bound Rab7a molecules through their switch and interswitch regions, creating a dyad Rab7-RILP(2)-Rab7 configuration [guerra-2016-multiple-roles-summary]. The N-terminal half of RILP recruits the dynein-dynactin motor complex by directly binding the C-terminal domain of p150Glued, the largest dynactin subunit [johansson-2007-dynein-activation-abstract].

RILP expression induces perinuclear accumulation of late endosomes and lysosomes by recruiting functional dynein-dynactin motor complexes that transport these organelles toward the minus end of microtubules [cantalupo-2001-rilp-abstract]. Beyond motor recruitment, RILP also regulates lysosomal acidification by binding the V1G1 subunit of V-ATPase, promoting vacuolar proton pump assembly [guerra-2016-multiple-roles-summary].

FYCO1 and Plus-End Microtubule Transport

FYCO1 (FYVE and coiled-coil domain containing 1) serves as the opposing force to RILP, mediating plus-end directed transport via kinesin motors [pankiv-2010-fyco1-abstract]. This ~180 kDa protein contains an N-terminal RUN domain, a central 850-amino acid coiled-coil region, a C-terminal FYVE domain that binds PI3P, and a GOLD domain unique among related proteins. FYCO1 preferentially interacts with GTP-bound Rab7a through its coiled-coil region, with conserved residues L1151 and W1152 being critical for this interaction [pankiv-2010-fyco1-abstract].

A distinctive feature of FYCO1 is its LC3-interacting region (LIR, amino acids 1276-1294), which enables direct binding to autophagosome-associated LC3B [pankiv-2010-fyco1-abstract]. This bifunctional architecture allows FYCO1 to bridge autophagosomes (via LC3) and kinesin motors, facilitating anterograde transport toward the cell periphery. Overexpression of RILP but not FYCO1 decreases FYCO1-decorated vesicles, indicating competition between these effectors for Rab7a binding and suggesting a regulatory mechanism for bidirectional transport control [pankiv-2010-fyco1-abstract].

ORP1L and ER Contact Sites

ORP1L (oxysterol-binding protein-related protein 1 Long) forms a tripartite complex with Rab7a and RILP, functioning as both an effector and a cholesterol sensor [vansteensel-2009-oorp1l-cholesterol-abstract]. The N-terminal ankyrin repeat domain (ARDN) of ORP1L binds Rab7a through a unique mechanism independent of the GTP/GDP binding state, utilizing helix3 (α3) and 310-helix 2 (η2) rather than the canonical effector-binding switch regions [guerra-2016-multiple-roles-summary]. This non-canonical interaction leaves the switch regions available for RILP binding, enabling formation of the ORP1L-Rab7-RILP tripartite complex [guerra-2016-multiple-roles-summary].

The C-terminal ORD domain of ORP1L senses cholesterol levels in late endosomal membranes [vansteensel-2009-oorp1l-cholesterol-abstract]. At low cholesterol levels, ORD adopts a conformation exposing an adjacent FFAT motif that binds the ER-resident VAP proteins, establishing ER-late endosome membrane contact sites. These contacts control late endosome positioning by modulating dynein-dynactin motor recruitment [vansteensel-2009-oorp1l-cholesterol-abstract].

Retromer Complex and Cargo Retrieval

Rab7a recruits the retromer complex to late endosomal membranes, enabling retrieval of sorting receptors to the trans-Golgi network (TGN) rather than their delivery to lysosomes for degradation [rojas-2008-retromer-recruitment-abstract]. Retromer consists of a cargo-binding trimer (Vps26, Vps29, Vps35) and a membrane-binding dimer of sorting nexins [rojas-2008-retromer-recruitment-abstract]. Rab7a binds retromer in a guanine nucleotide-dependent manner, and depletion of Rab7 causes retromer dissociation from membranes [rojas-2008-retromer-recruitment-abstract].

The best-characterized cargo for retromer is the cation-independent mannose-6-phosphate receptor (CI-MPR), which delivers acid hydrolases to lysosomes [rojas-2008-retromer-recruitment-abstract]. In Rab7-depleted cells, internalized CI-MPR accumulates in enlarged peripheral endosomes rather than being retrieved to the TGN, though receptor degradation is not increased, indicating the receptor is trapped rather than mis-routed to lysosomes [rojas-2008-retromer-recruitment-abstract].

HOPS Complex and Membrane Fusion

The HOPS (homotypic fusion and vacuole protein sorting) complex functions as a tethering factor essential for membrane fusion events involving late endosomes and lysosomes. In yeast, both Vps41 and Vps39 subunits bind the Rab7 homolog Ypt7 directly; however, in mammalian cells, the organization differs, with Arl8b rather than Rab7a recruiting Vps41 [guerra-2016-multiple-roles-summary]. RILP can recruit HOPS independently of Rab7 in mammalian cells, suggesting a more complex regulatory network [guerra-2016-multiple-roles-summary].

Receptor Degradation and Signal Termination

EGFR Trafficking and Degradation

A critical function of Rab7a is controlling the lysosomal degradation of activated receptor tyrosine kinases, particularly the epidermal growth factor receptor (EGFR). After ligand binding, EGFR is internalized via clathrin-coated pits, sorted through early endosomes to late endosomes/multivesicular bodies (LE/MVBs), and delivered to lysosomes for degradation [vanbergeijk-2009-egfr-degradation-abstract]. RNA interference studies demonstrated that loss of Rab7a decreases the rate of radiolabeled EGF degradation, while EGFR uptake remains normal, indicating that Rab7a is not required for receptor internalization but is essential for the final degradation step [vanbergeijk-2009-egfr-degradation-abstract].

Specifically, Rab7a is dispensable for delivery of cargo to the late endosome and for MVB biogenesis, but is required for efficient fusion of the LE/MVB to the lysosome [vanbergeijk-2009-egfr-degradation-abstract]. In Rab7-depleted cells, trafficking of the EGF-EGFR complex through the early endosome to the LE/MVB proceeds normally, but exit from this compartment is blocked, causing receptor accumulation rather than degradation.

Regulation of Rab7a in Receptor Signaling

Rab7a activity in receptor degradation is regulated by multiple kinases and phosphatases. LRRK1 phosphorylation of Rab7a at serine 72 increases association with RILP, enhancing minus-end transport of EGFR-containing endosomes through dynein-dependent mechanisms [khori-2018-rab7-regulation-summary]. Conversely, PTEN dephosphorylates Rab7a on conserved residues S72 and Y183, which are necessary for GDI-dependent recruitment of Rab7a to late endosomes [khori-2018-rab7-regulation-summary]. Src kinase phosphorylation of Rab7a at Y183 inhibits RILP binding, creating a regulatory node connecting growth factor signaling to endocytic trafficking [guerra-2016-multiple-roles-summary]. This phospho-regulation enables cells to modulate the balance between receptor recycling and degradation in response to varying signaling demands.

Phagosome Maturation and Innate Immunity

Beyond endocytosis, Rab7a plays essential roles in phagocytosis, the process by which professional phagocytes engulf and destroy pathogens. After internalization, phagosomes undergo a series of maturation steps, becoming increasingly acidified and ultimately fusing with lysosomes to form phagolysosomes [vieira-2001-phagosome-maturation-abstract]. The transition from early to late phagosomes mirrors the Rab5-to-Rab7 conversion seen in endosomal maturation.

Studies using dominant negative Rab7 mutants demonstrated that Rab7a regulates both early and late steps of phagosomal maturation [vieira-2001-phagosome-maturation-abstract]. Phagosomes in cells expressing dominant negative Rab7 contained very low levels of lysosomal membrane proteins and lacked mature lysosomal hydrolases, though they still formed multi-particle spacious phagosomes that remained abnormally acidic [vieira-2001-phagosome-maturation-abstract]. Rab7a recruits RILP to phagosomes, which in turn recruits the dynein-dynactin motor complex, enabling migration toward the microtubule-organizing center where lysosomal compartments concentrate.

Importantly, intracellular pathogens such as Mycobacterium tuberculosis have evolved mechanisms to subvert phagosomal maturation by interfering with Rab7 function. M. tuberculosis-containing phagosomes maintain an early phagosome state by preventing Rab7 recruitment, thereby avoiding lysosomal degradation [guerra-2016-multiple-roles-summary]. This makes Rab7a-dependent phagosome maturation a critical component of innate immune defense.

Role in Autophagy

Autophagosome-Lysosome Fusion

Rab7a has long been considered essential for autophagosome-lysosome fusion based on studies in yeast and Drosophila, where it coordinates fusion in concert with the syntaxin17-SNAP29-VAMP8 SNARE complex and the HOPS tethering complex [hyttinen-2013-maturation-review-summary]. However, CRISPR/Cas9-mediated knockout studies in mammalian cells have revealed a more nuanced picture [kuchitsu-2018-rab7-knockout-abstract].

Surprisingly, Rab7-knockout MDCK-II and HeLa cells accumulate autolysosomes (LC3-positive and Lamp2-positive structures) rather than autophagosomes under nutrient-rich conditions, indicating that autophagosome-lysosome fusion occurs even in the absence of Rab7a [kuchitsu-2018-rab7-knockout-abstract]. These findings demonstrate that in mammalian cells, Rab7a is essential for autolysosome maturation—the step following fusion—rather than for the fusion event itself. Remarkably, accumulated autolysosomes in Rab7-knockout cells cleared rapidly upon glutamine starvation, revealing an unidentified Rab7-independent mechanism activated under nutrient-depleted conditions [kuchitsu-2018-rab7-knockout-abstract].

Mitophagy

Rab7a plays specialized roles in mitophagy, the selective degradation of damaged mitochondria. During Parkin-mediated mitophagy, TBC1D15 controls Rab7a activity specifically at the outer mitochondrial membrane, where it is anchored through interaction with Fis1 [yamano-2014-mitophagy-abstract]. TBC1D15 associates with both mitochondria (via Fis1) and the isolation membrane (via LC3/GABARAP binding), constraining autophagosome morphogenesis to match the mitochondrial cargo [yamano-2014-mitophagy-abstract].

The retromer-TBC1D5 complex maintains pools of inactive, mobile Rab7a on endomembranes that can be recruited to mitochondria for mitophagy [seiwert-2022-retromer-mitophagy-abstract]. In cells lacking TBC1D5 or retromer, hyperactivated Rab7a accumulates on lysosomes and becomes depleted from other compartments, impairing mitophagy. These findings are clinically relevant as retromer mutations cause hereditary Parkinsonism linked to defective mitophagy [seiwert-2022-retromer-mitophagy-abstract].

Lipophagy

Rab7a serves as a central regulator of lipophagy, the selective autophagy of lipid droplets (LDs). Proteomic analyses of LDs from multiple organisms identified Rab7a as a conserved LD-associated protein, suggesting a universal role in LD regulation [pfeifer-2015-lipophagy-abstract]. In hepatocytes subjected to nutrient deprivation, Rab7a is indispensable for LD breakdown, with starvation leading to significantly increased Rab7a-LD association [pfeifer-2015-lipophagy-abstract].

The mechanism involves Rab7a-dependent recruitment of multivesicular bodies to the LD-autophagosome complex, inducing formation of amphisomes through fusion of autophagosomes and endosomes [pfeifer-2015-lipophagy-abstract]. Rab7a mutants defective in RILP binding fail to promote lipophagy, indicating that the RILP-dependent motor recruitment pathway is essential for this process [pfeifer-2015-lipophagy-abstract]. In adipocytes, LD-associated perilipin 1 (PLIN1) inhibits lipophagy by blocking Rab7a binding to the LD surface, providing a regulatory mechanism linking lipid storage to autophagic degradation [pfeifer-2015-lipophagy-abstract].

Charcot-Marie-Tooth Disease Type 2B

Clinical Features and Genetics

RAB7A mutations cause Charcot-Marie-Tooth type 2B (CMT2B), an autosomal dominant axonal peripheral neuropathy clinically characterized by prominent sensory loss, distal muscle weakness leading to muscle atrophy, high frequency of foot ulcers, and infections often resulting in toe amputations [romano-2021-cmt2b-summary]. The disease presents unusually early, typically in the second or third decade of life. Five missense mutations have been identified in patients from multiple families: L129F, K157N, N161T/I, and V162M, all displaying the characteristic ulcero-mutilating phenotype with variable motor involvement [romano-2021-cmt2b-summary]. A novel mutation, K126R, was recently identified and associated with inhibited EGFR degradation [romano-2021-cmt2b-summary].

Molecular Mechanisms of Pathogenesis

The pathomechanism of CMT2B remains debated, with evidence supporting both gain-of-function and loss-of-function hypotheses [conejero-2017-cmt2b-ngf-summary]. The gain-of-function model proposes that CMT2B mutations decrease nucleotide affinity, causing unregulated nucleotide exchange and resulting in an increased fraction of active, GTP-bound Rab7a [conejero-2017-cmt2b-ngf-summary]. CMT2B mutants demonstrate enhanced binding to effectors including RILP, Vps13C, ORP1L, and Rabring7, consistent with constitutively active behavior [conejero-2017-cmt2b-ngf-summary].

Hyperactive Rab7a is proposed to impair nerve growth factor (NGF) signaling through two mechanisms [conejero-2017-cmt2b-ngf-summary]. First, accelerated vesicle transport may cause premature fusion and degradation of signal-carrying Rab5 endosomes before trophic signals reach the neuronal soma. Second, mutant-containing vesicles could aggregate near the nucleus, blocking retrograde transport of survival signals from distal axons [conejero-2017-cmt2b-ngf-summary].

Alternative evidence from Drosophila supports a loss-of-function mechanism [chen-2017-drosophila-cmt2b-abstract]. Loss of Rab7, but not overexpression of CMT2B mutants, causes adult-onset neurodegeneration in fly photosensory neurons, with quantitative assays revealing that all CMT2B mutant proteins retain only 10-50% of wild-type function [chen-2017-drosophila-cmt2b-abstract]. Additionally, CMT2B mutants bind more strongly to the intermediate filament protein peripherin and cause a significant increase in soluble peripherin [romano-2021-cmt2b-summary]. Since peripherin functions in neurite outgrowth and axonal regeneration, altered Rab7a-peripherin interaction may contribute to CMT2B neuropathy [romano-2021-cmt2b-summary].

Recent work has also implicated mitochondrial dysfunction in CMT2B [conejero-2017-cmt2b-ngf-summary]. CMT2B Rab7 mutations markedly decrease axonal protein synthesis, impair mitochondrial function, and compromise axonal viability. Expression of CMT2B mutations at physiological levels enhances Drp1 activity to promote mitochondrial fission, potentially underlying selective vulnerability of peripheral sensory neurons [conejero-2017-cmt2b-ngf-summary].

Other Disease Associations

Beyond CMT2B, Rab7a dysregulation has been implicated in various pathological conditions. In cancer, Rab7a exhibits context-dependent roles: it functions as a tumor suppressor by promoting degradation of growth factor receptors such as EGFR and HER2, yet in melanoma progression, Myc upregulates Rab7a initially before selective downregulation accompanies metastatic transition [guerra-2016-multiple-roles-summary]. Rab7a regulates lysosomal exocytosis of cathepsin B, and its silencing increases cancer cell invasion [guerra-2016-multiple-roles-summary].

In Parkinson's disease, Parkin ubiquitinates Rab7a at lysine 38 to enhance retromer function, linking Rab7a regulation to the pathways affected in this neurodegenerative disorder [guerra-2016-multiple-roles-summary]. Age-related decline in Rab7a activity results in impaired trafficking of autophagosomes to lysosomes, contributing to inefficient clearance of damaged organelles and aggregated proteins that increases vulnerability to neurodegeneration [hyttinen-2013-maturation-review-summary]. Rab7a dysfunction has also been associated with long QT syndrome through altered KCNQ1/KCNE1 channel trafficking, hepatitis B through effects on HBV secretion, and diabetic neuropathy through impaired μ-opioid receptor trafficking [guerra-2016-multiple-roles-summary].

Open Questions

Several important questions remain regarding RAB7A function and regulation. First, the precise mechanism by which Rab7a contributes to autophagosome-lysosome fusion in mammalian cells requires clarification, particularly given the unexpected finding that Rab7-knockout cells still undergo this fusion step. The Rab7-independent mechanism activated during glutamine starvation that enables autolysosome clearance remains unidentified [kuchitsu-2018-rab7-knockout-abstract].

Second, the pathomechanism of CMT2B requires resolution of the apparent contradiction between gain-of-function evidence in mammalian systems and loss-of-function evidence in Drosophila models [chen-2017-drosophila-cmt2b-abstract]. Better disease models in rodents and human neurons are needed to precisely define how RAB7A mutations cause selective vulnerability of peripheral sensory neurons while sparing other cell types.

Third, how cells coordinate the opposing activities of RILP and FYCO1 to achieve bidirectional transport of late endosomes and autophagosomes remains incompletely understood. The competition between these effectors for Rab7a binding suggests a potential regulatory mechanism, but the upstream signals controlling this competition are largely unknown [pankiv-2010-fyco1-abstract].

Fourth, the function of the Bulli/RMC1 subunit in the metazoan Mon1-Ccz1 complex remains elusive [khori-2018-rab7-regulation-summary]. Understanding its role may reveal additional regulatory mechanisms for Rab7a activation in multicellular organisms.

Finally, the full extent of Rab7a's post-translational modifications and their functional consequences requires further investigation. Beyond prenylation, phosphorylation at tyrosine 183 by Src kinase inhibits RILP binding, but the regulatory contexts for this and other modifications remain to be fully characterized [guerra-2016-multiple-roles-summary].

References

1. bucci-2000-lysosome-biogenesis: Bucci C, Thomsen P, Nicoziani P, McCarthy J, van Deurs B. Rab7: a key to lysosome biogenesis. Mol Biol Cell. 2000 Feb;11(2):467-80. PMID: 10679007. https://pubmed.ncbi.nlm.nih.gov/10679007/

2. cai-2022-mon1-ccz1-structure: Cai X, et al. Structure of the Mon1-Ccz1 complex reveals molecular basis of membrane binding for Rab7 activation. Proc Natl Acad Sci USA. 2022 Jan 25;119(4):e2121494119. PMID: 35105815. DOI: 10.1073/pnas.2121494119. https://pmc.ncbi.nlm.nih.gov/articles/PMC8833172/

3. cantalupo-2001-rilp: Cantalupo G, Alifano P, Roberti V, Bruni CB, Bucci C. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr Biol. 2001 Nov 13;11(21):1681-5. PMID: 11696325. DOI: 10.1016/s0960-9822(01)00531-0. https://pubmed.ncbi.nlm.nih.gov/11696325/

4. chen-2017-drosophila-cmt2b: Chen Y, et al. Charcot-Marie-Tooth 2b associated Rab7 mutations cause axon growth and guidance defects during vertebrate sensory neuron development. Neural Dev. 2016 Mar 8;11:5. PMID: 26956926. DOI: 10.1186/s13064-016-0058-x. https://link.springer.com/article/10.1186/s13064-016-0058-x

5. conejero-2017-cmt2b-ngf: Conejero-Goldberg C, et al. Charcot Marie Tooth 2B Peripheral Sensory Neuropathy: How Rab7 Mutations Impact NGF Signaling? Int J Mol Sci. 2017 Feb 7;18(2):324. PMID: 28178201. PMCID: PMC5343860. DOI: 10.3390/ijms18020324. https://pmc.ncbi.nlm.nih.gov/articles/PMC5343860/

6. guerra-2016-multiple-roles: Guerra F, Bucci C. Multiple Roles of the Small GTPase Rab7. Cells. 2016 Sep 22;5(3):34. PMID: 27669304. PMCID: PMC5040976. DOI: 10.3390/cells5030034. https://pmc.ncbi.nlm.nih.gov/articles/PMC5040976/

7. hyttinen-2013-maturation-review: Hyttinen JM, Niittykoski M, Salminen A, Kaarniranta K. Maturation of autophagosomes and endosomes: A key role for Rab7. Biochim Biophys Acta. 2013 Mar;1833(3):503-10. PMID: 23220125. DOI: 10.1016/j.bbamcr.2012.11.018. https://www.sciencedirect.com/science/article/pii/S0167488912003503

8. johansson-2007-dynein-activation: Johansson M, Rocha N, et al. Activation of endosomal dynein motors by stepwise assembly of Rab7-RILP-p150Glued, ORP1L, and the receptor βIII spectrin. J Cell Biol. 2007 Feb 12;176(4):459-71. PMID: 17283181. PMCID: PMC2063981. DOI: 10.1083/jcb.200608103. https://pmc.ncbi.nlm.nih.gov/articles/PMC2063981/

9. khori-2018-rab7-regulation: Khorie F, Bucci C. This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy. Front Cell Dev Biol. 2018 Oct 2;6:129. PMID: 30333971. PMCID: PMC6176412. DOI: 10.3389/fcell.2018.00129. https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/

10. kuchitsu-2018-rab7-knockout: Kuchitsu Y, Fukuda M. Revisiting Rab7 Functions in Mammalian Autophagy: Rab7 Knockout Studies. Cells. 2018 Nov 2;7(11):193. PMID: 30400151. PMCID: PMC6262614. DOI: 10.3390/cells7110193. https://pmc.ncbi.nlm.nih.gov/articles/PMC6262614/

11. pankiv-2010-fyco1: Pankiv S, Alemu EA, et al. FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end-directed vesicle transport. J Cell Biol. 2010 Jan 25;188(2):253-69. PMID: 20100911. PMCID: PMC2812517. DOI: 10.1083/jcb.200907015. https://pmc.ncbi.nlm.nih.gov/articles/PMC2812517/

12. poteryaev-2010-switch: Poteryaev D, Datta S, Ackema K, Zerial M, Spang A. Identification of the switch in early-to-late endosome transition. Cell. 2010 Apr 16;141(3):497-508. PMID: 20434987. DOI: 10.1016/j.cell.2010.03.011. https://pubmed.ncbi.nlm.nih.gov/20434987/

13. rink-2005-rab-conversion: Rink J, Ghigo E, Kalaidzidis Y, Zerial M. Rab conversion as a mechanism of progression from early to late endosomes. Cell. 2005 Sep 9;122(5):735-49. PMID: 16139902. DOI: 10.1016/j.cell.2005.06.043. https://pubmed.ncbi.nlm.nih.gov/16139902/

14. rojas-2008-retromer-recruitment: Rojas R, et al. Regulation of retromer recruitment to endosomes by sequential action of Rab5 and Rab7. J Cell Biol. 2008 Nov 3;183(3):513-26. PMID: 18955555. PMCID: PMC2575791. DOI: 10.1083/jcb.200804048. https://pmc.ncbi.nlm.nih.gov/articles/PMC2575791/

15. romano-2021-cmt2b: Romano R, et al. Charcot-Marie-Tooth Type 2B: A New Phenotype Associated with a Novel RAB7A Mutation and Inhibited EGFR Degradation. Cells. 2020 Apr 18;9(4):1028. PMID: 32326241. PMCID: PMC7226405. DOI: 10.3390/cells9041028. https://pmc.ncbi.nlm.nih.gov/articles/PMC7226405/

16. seiwert-2022-retromer-mitophagy: Seiwert N, et al. Control of RAB7 activity and localization through the retromer-TBC1D5 complex enables RAB7-dependent mitophagy. EMBO J. 2017 Dec 15;36(24):3563-3585. PMID: 29158324. DOI: 10.15252/embj.201797128. https://www.embopress.org/doi/full/10.15252/embj.201797128

17. vansteensel-2009-oorp1l-cholesterol: Rocha N, Kuijl C, et al. Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150Glued and late endosome positioning. J Cell Biol. 2009 Jun 29;185(7):1209-25. PMID: 19564404. DOI: 10.1083/jcb.200811005. https://rupress.org/jcb/article/185/7/1209/35449/Cholesterol-sensor-ORP1L-contacts-the-ER-protein

18. yamano-2014-mitophagy: Yamano K, Fogel AI, et al. Mitochondrial Rab GAPs govern autophagosome biogenesis during mitophagy. eLife. 2014 Feb 25;3:e01612. PMID: 24569479. DOI: 10.7554/eLife.01612. https://elifesciences.org/articles/01612

19. vanbergeijk-2009-egfr-degradation: Vanbergeijk P, et al. Rab7 regulates late endocytic trafficking downstream of multivesicular body biogenesis and cargo sequestration. J Biol Chem. 2009 May 8;284(19):12110-24. PMID: 19265192. PMCID: PMC2673280. DOI: 10.1074/jbc.M809277200. https://pmc.ncbi.nlm.nih.gov/articles/PMC2673280/

20. pfeifer-2015-lipophagy: Pfeifer C, et al. The small GTPase Rab7 as a central regulator of hepatocellular lipophagy. Hepatology. 2015 Apr;61(4):1270-4. PMID: 25565581. DOI: 10.1002/hep.27667. https://pubmed.ncbi.nlm.nih.gov/25565581/

21. vieira-2001-phagosome-maturation: Vieira OV, Bucci C, et al. Rab7 regulates phagosome maturation in Dictyostelium. J Cell Sci. 2001 Jul;114(Pt 13):2449-60. PMID: 11559753. https://pubmed.ncbi.nlm.nih.gov/11559753/

Citations

1. bucci-2000-lysosome-biogenesis-abstract.md
2. cai-2022-mon1-ccz1-structure-abstract.md
3. cantalupo-2001-rilp-abstract.md
4. chen-2017-drosophila-cmt2b-abstract.md
5. conejero-2017-cmt2b-ngf-summary.md
6. guerra-2016-multiple-roles-summary.md
7. hyttinen-2013-maturation-review-summary.md
8. johansson-2007-dynein-activation-abstract.md
9. khori-2018-rab7-regulation-summary.md
10. kuchitsu-2018-rab7-knockout-abstract.md
11. pankiv-2010-fyco1-abstract.md
12. pfeifer-2015-lipophagy-abstract.md
13. poteryaev-2010-switch-abstract.md
14. rink-2005-rab-conversion-abstract.md
15. rojas-2008-retromer-recruitment-abstract.md
16. romano-2021-cmt2b-summary.md
17. seiwert-2022-retromer-mitophagy-abstract.md
18. vanbergeijk-2009-egfr-degradation-abstract.md
19. vansteensel-2009-oorp1l-cholesterol-abstract.md
20. vieira-2001-phagosome-maturation-abstract.md
21. yamano-2014-mitophagy-abstract.md

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan status: We verified gene identity; gathered recent primary/review evidence with emphasis on 2023–2024; synthesized molecular function, regulators, localization, pathways, effectors; summarized disease relevance and applications; extracted quantitative/mechanistic details where supported; and created a summary artifact.

Gene/protein verification and identity
- Target: RAB7A, Ras-related protein Rab-7a, Homo sapiens. Member of the small GTPase Rab family with P-loop NTPase/small GTP-binding fold. Functions as a membrane trafficking switch on late endosomes/lysosomes/autophagosomes. This identity and family context are consistent with recent mechanistic studies of Rab7 activation during Rab5→Rab7 endosome maturation (Mon1–Ccz1 GEF) (Borchers et al., PNAS, 2023, published Jul 2023; https://doi.org/10.1073/pnas.2303750120) (borchers2023regulatorysitesin pages 1-2). Rab7A’s canonical cycle and localization to late endosomes/lysosomes are reiterated in contemporary sources (Wong, 2024; unknown journal) (wong2024ampkregulatesthe pages 58-62, wong2024ampkregulatesthe pages 62-66), and in a 2023 neuron-focused review (Mulligan & Winckler, Biomolecules, Sep 2023; https://doi.org/10.3390/biom13091399) (mulligan2023regulationofendosomal pages 2-4).

Molecular function and enzymatic cycle (EC 3.6.5.2)
- Biochemical role: Small GTPase molecular switch. GDP-bound Rab7A is cytosolic/inactive; GTP-bound Rab7A is membrane-associated/active and recruits effectors to control trafficking, fusion, and motility of late endosomes/lysosomes and autophagosomes (Valencia, 2024; review context; unknown journal) (valencia2024rab7palmitoylationbya pages 51-54, valencia2024rab7palmitoylationby pages 51-54).
- GEF-mediated activation: The Mon1–Ccz1 complex is the principal Rab7 GEF on endosomal membranes; recruitment and activity are stimulated by Rab5 to drive the Rab5→Rab7 conversion central to endosomal maturation. 2023 structural/biochemical work identified (i) an autoinhibitory, intrinsically disordered Mon1 N-terminus that limits Rab5-dependent GEF activity and (ii) a conserved Rab5-binding site on Mon1 essential for membrane GEF function and maturation in vivo (Borchers et al., PNAS, 2023; https://doi.org/10.1073/pnas.2303750120) (borchers2023regulatorysitesin pages 1-2).
- Accessory subunits: C5orf51 and the trimeric MCC (Mon1–Ccz1–C18orf8/RMC1) module stabilize Rab7 activation and positioning of the GEF; C5orf51 binds GDP-locked RAB7A and interacts with MON1/CCZ1, supporting Rab7 localization and stability (Valencia, 2024; review synopsis) (valencia2024rab7palmitoylationbya pages 51-54, valencia2024rab7palmitoylationby pages 51-54).
- GAP-mediated inactivation: TBC-domain GAPs such as TBC1D15 and TBC1D5 stimulate Rab7 GTP hydrolysis and membrane release; TBC1D5 links to retromer and autophagy machinery, whereas TBC1D15 associates with mitochondria via Fis1, influencing mitophagy and autophagosome size (Wong, 2024; unknown journal) (wong2024ampkregulatesthe pages 62-66).
- Post-translational regulation: Rab7A is subject to ubiquitylation and phosphorylation (e.g., S72; Y183) and lipidation such as palmitoylation; these PTMs modulate effector interactions and trafficking outputs (Valencia, 2024; unknown journal) (valencia2024rab7palmitoylationbya pages 51-54, valencia2024rab7palmitoylationby pages 51-54).

Subcellular localization and core cellular roles
- Localization: Late endosomes/multivesicular bodies and lysosomes are primary sites; Rab7A also acts on autophagosomes and can be recruited to damaged mitochondria during Parkin/PINK1-dependent mitophagy (Cai et al., Autophagy, Jun 2021; https://doi.org/10.1080/15548627.2020.1760623) (cai2021nrbf2isa pages 1-3). Contemporary reviews reiterate LE/lysosomal Rab7A localization and functions (Wong, 2024) (wong2024ampkregulatesthe pages 58-62, wong2024ampkregulatesthe pages 62-66).
- Endosome maturation: Rab7A is activated by Mon1–Ccz1 downstream of Rab5, marking the transition from early to late endosomes and enabling recruitment of late endosomal effectors, acidification, and maturation (Borchers et al., 2023; https://doi.org/10.1073/pnas.2303750120) (borchers2023regulatorysitesin pages 1-2).
- Autophagosome–lysosome fusion and autophagic flux: Rab7A recruits fusion tethers and effectors to promote autophagosome maturation and autolysosome formation; NRBF2 functions as a Rab7 effector that sustains Mon1–Ccz1 GEF activity and thereby Rab7-GTP generation on maturing autophagic compartments (Cai et al., 2021; https://doi.org/10.1080/15548627.2020.1760623) (cai2021nrbf2isa pages 1-3). Recent mechanistic summaries emphasize HOPS as a Rab7 effector tether for LE/lysosome and autophagosome fusion (Wong, 2024) (wong2024ampkregulatesthe pages 62-66).
- Acidification coupling and pH sensing: Acute collapse of late endosome pH triggers rapid Rab7 hyperactivation via increased assembly of the V-ATPase V1G1 subunit and stabilization of Rab7-GTP through RILP, with functional consequences on CI-M6PR tubulation/retrieval (Mulligan et al., J Cell Sci, May 2024; https://doi.org/10.1242/jcs.261765) (mulligan2024collapseoflate pages 1-4).
- Mitophagy: Rab7A participates in Parkin/PINK1-dependent mitophagy, including recruitment to damaged mitochondria and coordination with Mon1–Ccz1 and PI3KC3 complexes; NRBF2 maintains the Mon1–Ccz1 GEF–Rab7 axis necessary for autophagosome maturation on APP-containing and autophagic cargo vesicles (Cai et al., 2021; https://doi.org/10.1080/15548627.2020.1760623) (cai2021nrbf2isa pages 1-3).
- Lipid droplet turnover (lipophagy/microlipophagy): Rab7A is implicated in lipid droplet catabolism via late endosome/lysosome pathways in both macrolipophagy and contact/fusion processes; mechanistic overviews place Rab7A at the autophagic–endo-lysosomal interface controlling cargo delivery and degradation (Wong, 2024; unknown journal) (wong2024ampkregulatesthe pages 58-62, wong2024ampkregulatesthe pages 62-66).

Principal effectors and pathway modules
- Motor recruitment and positioning: RILP is a canonical Rab7 effector that binds dynein–dynactin to drive minus-end transport and perinuclear late endosome/lysosome positioning; RILP also links to the V-ATPase (V1G1) during pH-triggered responses (Mulligan et al., 2024; https://doi.org/10.1242/jcs.261765) (mulligan2024collapseoflate pages 1-4). Reviews also place RILP and FYCO1 as opposing directional adaptors on Rab7-positive organelles (Wong, 2024) (wong2024ampkregulatesthe pages 62-66).
- Tethering and fusion: HOPS complex functions as a Rab7 effector to tether late endosomes and autophagosomes to lysosomes prior to SNARE-mediated fusion (Wong, 2024) (wong2024ampkregulatesthe pages 62-66).
- Cargo recycling and maturation: Retromer (VPS35/VPS26/VPS29) associates with Rab7-positive endosomes to mediate retrograde transport (e.g., CI-M6PR retrieval) and regulate endosome maturation; dysfunction of Rab7–retromer coupling perturbs hydrolase sorting (Valencia, 2024; unknown journal) (valencia2024rab7palmitoylationby pages 51-54).
- Contact site and lipid/cholesterol regulation: ORP1L (oxysterol-binding protein-related protein) and PLEKHM1 act as Rab7 effectors coordinating contacts and tethering/fusion of late endosome/lysosome compartments; PLEKHM1 supports HOPS recruitment and autophagosome–lysosome fusion (Valencia, 2024; unknown journal) (valencia2024rab7palmitoylationby pages 51-54).
- Autophagy maturation scaffold: NRBF2 directly binds Rab7 and supports CCZ1–MON1A GEF function and PI3KC3 activity for autophagosome maturation (Cai et al., 2021; https://doi.org/10.1080/15548627.2020.1760623) (cai2021nrbf2isa pages 1-3).

Recent (2023–2024) developments
- Mon1–Ccz1 GEF regulation: Comprehensive 2023 PNAS study demonstrated autoinhibitory control within Mon1 and a critical Rab5-binding site enabling Rab5-stimulated GEF activity on membranes, thereby directly linking Rab5 presence to Rab7 activation and endosome maturation (Borchers et al., PNAS, Jul 2023; https://doi.org/10.1073/pnas.2303750120) (borchers2023regulatorysitesin pages 1-2).
- pH-coupled Rab7 activation: Neutralization of late endosomal pH rapidly hyperactivates Rab7 via V-ATPase V1G1 assembly and RILP, disrupting tubulation and CI-M6PR recycling (Mulligan et al., J Cell Sci, May 2024; https://doi.org/10.1242/jcs.261765) (mulligan2024collapseoflate pages 1-4).
- Neuronal trafficking and CMT2B insights: A 2023 review synthesizes evidence that CMT2B-linked RAB7A alleles show increased nucleotide exchange and elevated GTP-bound state (“rapid cycling”), altered effector balance, and defects in endosomal receptor (e.g., TrkA) trafficking in neurons, consistent with disrupted trophic signaling; the review summarizes model and patient-cell findings linking altered autophagy and mitochondrial dynamics (Mulligan & Winckler, Biomolecules, Sep 2023; https://doi.org/10.3390/biom13091399) (mulligan2023regulationofendosomal pages 2-4).
- Autophagosome maturation checkpoint: NRBF2 as a Rab7 effector that sustains Mon1–Ccz1 GEF and PI3KC3 activities, coupling autophagosome maturation with Rab7 activation on autolysosomal compartments; this mechanistic link informs neurodegeneration and APP-CTF turnover (Cai et al., Autophagy, 2021; https://doi.org/10.1080/15548627.2020.1760623) (cai2021nrbf2isa pages 1-3).

Disease relevance, applications, and real-world implementations
- CMT2B neuropathy: Dominant missense RAB7A alleles in CMT2B alter GTPase cycling and endosomal trafficking in neurons, with consensus that mutants exhibit increased activation/“rapid cycling,” perturbing neurotrophin receptor trafficking, autophagosome dynamics, and mitochondrial homeostasis; these mechanisms suggest targets along the Rab7 activation cycle and effector interactions for therapeutic exploration (Mulligan & Winckler, 2023; https://doi.org/10.3390/biom13091399) (mulligan2023regulationofendosomal pages 2-4).
- Cancer and signaling: Rab7A–retromer–lysosome axis controls receptor downregulation (e.g., EGFR) and proteostasis; Rab7A PTMs (e.g., Y183, S72) and effector networks influence degradative flux and endosomal signaling crosstalk, with implications for oncogenic pathways and lysosomal stress responses (Valencia, 2024; unknown journal) (valencia2024rab7palmitoylationbya pages 51-54, valencia2024rab7palmitoylationby pages 51-54). V-ATPase–RILP–Rab7A coupling to luminal pH provides a direct mechanistic entrypoint for modulating endolysosomal signaling in disease (Mulligan et al., 2024; https://doi.org/10.1242/jcs.261765) (mulligan2024collapseoflate pages 1-4).
- Infection/host–pathogen interactions: Contemporary overviews reiterate that Rab7A coordinates degradative endolysosomal traffic and autophagosome maturation, pathways often manipulated by pathogens; control nodes include the Mon1–Ccz1 GEF, HOPS tether, and Rab7 GAPs (Wong, 2024; unknown journal) (wong2024ampkregulatesthe pages 62-66).

Selected quantitative/mechanistic data
- Endosome maturation switch: Loss of Mon1 Rab5-binding or GEF autoinhibition control impairs Rab7 activation on membranes and causes in vivo growth defects and shifts in endosomal identities in Drosophila/yeast models, supporting the causal mechanism of Rab5-stimulated Mon1–Ccz1 GEF activity (Borchers et al., 2023; https://doi.org/10.1073/pnas.2303750120) (borchers2023regulatorysitesin pages 1-2).
- pH-triggered Rab7 hyperactivation: Acute LE pH neutralization phenocopies Rab7 hyperactive states with defects in CI-M6PR recycling/tubulation; mechanistically, increased V1G1 assembly stabilizes Rab7-GTP through RILP (Mulligan et al., 2024; https://doi.org/10.1242/jcs.261765) (mulligan2024collapseoflate pages 1-4).
- CMT2B mutant behavior: Integrative 2023 review concludes CMT2B variants elevate GTP-bound fractions and alter GTPase cycling independent of GEF, with downstream autophagy/mitochondrial dynamics changes in neuronal models and patient-derived cells (Mulligan & Winckler, 2023; https://doi.org/10.3390/biom13091399) (mulligan2023regulationofendosomal pages 2-4).

Key regulators/cargo modules (concise)
- GEFs: Mon1–Ccz1 (Rab5-stimulated; autoinhibited Mon1 N-terminus; essential Rab5-binding site) (Borchers et al., 2023; https://doi.org/10.1073/pnas.2303750120) (borchers2023regulatorysitesin pages 1-2).
- GAPs: TBC1D5 (retromer-linked), TBC1D15 (mitochondria/mitophagy), and other TBC-domain GAPs regulating late endosome/autophagy dynamics (Wong, 2024) (wong2024ampkregulatesthe pages 62-66).
- Effectors: RILP (dynein/dynactin; V-ATPase V1G1 linkage), HOPS (tethering/fusion), retromer/VPS35 (retrograde sorting), ORP1L and PLEKHM1 (contact and tether/fusion coordination), NRBF2 (Rab7 effector sustaining Mon1–Ccz1/PI3KC3) (Mulligan et al., 2024; Cai et al., 2021; Valencia, 2024) (mulligan2024collapseoflate pages 1-4, cai2021nrbf2isa pages 1-3, valencia2024rab7palmitoylationby pages 51-54).

Embedded summary table
| Feature | Summary | Key citations |
|---|---|---|
| Identity verification | RAB7A (UniProt P51149); organism: Homo sapiens; small GTPase, Rab family; domains: P-loop NTPase / small GTP-binding (Ras) fold. | Borchers et al., 2023; https://doi.org/10.1073/pnas.2303750120 (borchers2023regulatorysitesin pages 1-2) |
| Molecular function | Small GTPase (EC 3.6.5.2): cycles between GDP- (inactive) and GTP- (active) bound states to recruit effectors; GTP hydrolysis drives state change. | Valencia 2024 (reviewed regulatory PTMs and cycle) (valencia2024rab7palmitoylationbya pages 51-54, valencia2024rab7palmitoylationby pages 51-54) |
| Primary regulators | GEFs: Mon1–Ccz1 (with C18orf8/RMC1 accessory subunit) activate Rab7; GAPs: TBC1D15, TBC1D5 (and related TBC proteins) inactivate Rab7. | Mon1–Ccz1 regulatory/GEF work: Borchers et al., 2023; Mon1–Ccz1 functional context (borchers2023regulatorysitesin pages 1-2); GAP roles (reviews) (wong2024ampkregulatesthe pages 62-66) |
| Key effectors | RILP (dynein recruitment), HOPS (tethering/fusion), retromer/VPS35 (retrograde sorting), ORP1L, PLEKHM1, NRBF2 (autophagosome maturation effector). | NRBF2 functional link: Cai et al., 2021; https://doi.org/10.1080/15548627.2020.1760623 (cai2021nrbf2isa pages 1-3); effector summaries (valencia2024rab7palmitoylationby pages 51-54) |
| Principal localizations | Late endosomes, multivesicular bodies, lysosomes, autophagosomes; recruited transiently to damaged mitochondria during mitophagy; participates in ER–mitochondria–lysosome membrane contact sites. | Autophagy/membrane sites & Rab7 roles: Cai et al., 2021 (cai2021nrbf2isa pages 1-3); endosomal pH/Rab7 coupling: Mulligan et al., 2024; https://doi.org/10.1242/jcs.261765 (mulligan2024collapseoflate pages 1-4) |
| Core pathways | Endosome maturation (Rab5 → Rab7 conversion); autophagosome–lysosome fusion and autophagic flux; mitophagy (Parkin/PINK1/TBK1-linked recruitment); lipophagy/microlipophagy (LD turnover). | Mon1–Ccz1 Rab conversion: Borchers et al., 2023 (borchers2023regulatorysitesin pages 1-2); mitophagy/autophagy links: Cai et al., 2021 (cai2021nrbf2isa pages 1-3); pathway reviews (wong2024ampkregulatesthe pages 62-66) |
| Selected 2023–2024 advances | 1) Mon1–Ccz1 autoinhibition and conserved Rab5-binding site that controls Rab5→Rab7 conversion (Borchers 2023). 2) LE pH neutralization drives rapid Rab7 hyper-activation via V-ATPase V1G1 assembly and RILP stabilization (Mulligan 2024). 3) NRBF2 identified as a Rab7 effector that supports Mon1–Ccz1 GEF activity and autophagosome maturation (Cai 2021; mechanistic relevance emphasized in recent work). 4) Mechanistic/neuronal studies clarify CMT2B mutant behavior (constitutively higher GTP-bound fractions and disrupted autophagy/mitochondrial dynamics). | Borchers et al., 2023; https://doi.org/10.1073/pnas.2303750120 (borchers2023regulatorysitesin pages 1-2); Mulligan et al., 2024; https://doi.org/10.1242/jcs.261765 (mulligan2024collapseoflate pages 1-4); Cai et al., 2021; https://doi.org/10.1080/15548627.2020.1760623 (cai2021nrbf2isa pages 1-3); Mulligan & Winckler 2023 (CMT2B review) https://doi.org/10.3390/biom13091399 (mulligan2023regulationofendosomal pages 2-4) |
| Disease notes / applications | CMT2B: dominant RAB7A missense mutations (e.g., V162M, K126R, others) show increased nucleotide exchange / higher GTP-bound fraction and impaired autophagic flux and mitochondrial defects in patient cells and models; implications in neurodegeneration. Emerging roles in cancer and infection via dysregulated endolysosomal trafficking and signaling. | CMT2B functional data and review: Mulligan & Winckler, 2023; https://doi.org/10.3390/biom13091399 (mulligan2023regulationofendosomal pages 2-4); mitochondrial/autophagy links: Gu et al., 2022 (discussed in reviews captured) (mulligan2023regulationofendosomal pages 2-4, cai2021nrbf2isa pages 1-3) |

Table: Compact reference table summarizing identity, function, regulators, effectors, localization, key pathways, recent advances (2023–2024), and disease notes for human RAB7A (UniProt P51149), with primary citations to the collected evidence.

Expert perspectives and consensus
- Converging data place Rab7A as the central organizer of the degradative endolysosomal/autophagic pathway in mammalian cells, with GEFs (Mon1–Ccz1–C18orf8/RMC1), GAPs (TBC1D15/D5), and effectors (RILP/HOPS/retromer/PLEKHM1/NRBF2) forming a modular network tuned by Rab5 input and luminal pH. Recent work refined how Rab5 presence licenses Mon1–Ccz1 activity and revealed a V-ATPase–RILP axis that ties luminal pH to Rab7 activation, providing concrete mechanisms for trafficking defects observed across neurodegeneration, infection, and cancer models (Borchers et al., 2023; Mulligan et al., 2024) (borchers2023regulatorysitesin pages 1-2, mulligan2024collapseoflate pages 1-4).

Limitations and open questions
- While neuronal disease mechanisms implicate elevated Rab7-GTP and altered effector balance in CMT2B, precise, quantitative, variant-specific kinetics and structural determinants in human cells remain incompletely defined, and will benefit from systematic, allele-by-allele biochemical and proximity-mapping studies integrated with live-cell trafficking metrics (Mulligan & Winckler, 2023; https://doi.org/10.3390/biom13091399) (mulligan2023regulationofendosomal pages 2-4).

References (URLs and dates)
- Borchers AC et al. Regulatory sites in the Mon1–Ccz1 complex control Rab5 to Rab7 transition and endosome maturation. PNAS. Jul 2023. https://doi.org/10.1073/pnas.2303750120 (borchers2023regulatorysitesin pages 1-2)
- Mulligan RJ et al. Collapse of late endosomal pH elicits a rapid Rab7 response via the V-ATPase and RILP. Journal of Cell Science. May 2024. https://doi.org/10.1242/jcs.261765 (mulligan2024collapseoflate pages 1-4)
- Mulligan RJ, Winckler B. Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from CMT2B Disease. Biomolecules. Sep 2023. https://doi.org/10.3390/biom13091399 (mulligan2023regulationofendosomal pages 2-4)
- Cai C-Z et al. NRBF2 is a RAB7 effector required for autophagosome maturation and mediates the association of APP-CTFs with active RAB7 for degradation. Autophagy. Jun 2021. https://doi.org/10.1080/15548627.2020.1760623 (cai2021nrbf2isa pages 1-3)
- Valencia LDT. Rab7 palmitoylation by zdhhc11 and phosphorylation by nek7 as modulators of endo-lysosomal trafficking in batten disease. 2024. (review-style excerpt). (valencia2024rab7palmitoylationbya pages 51-54, valencia2024rab7palmitoylationby pages 51-54)
- Wong C. AMPK regulates the release of exosomal miRNAs… 2024. (sections summarizing Rab7 regulation and effectors). (wong2024ampkregulatesthe pages 58-62, wong2024ampkregulatesthe pages 62-66)

References

1. (borchers2023regulatorysitesin pages 1-2): Ann-Christin Borchers, Maren Janz, Jan-Hannes Schäfer, Arne Moeller, Daniel Kümmel, Achim Paululat, Christian Ungermann, and Lars Langemeyer. Regulatory sites in the mon1–ccz1 complex control rab5 to rab7 transition and endosome maturation. Proceedings of the National Academy of Sciences, Jul 2023. URL: https://doi.org/10.1073/pnas.2303750120, doi:10.1073/pnas.2303750120. This article has 23 citations and is from a highest quality peer-reviewed journal.

2. (wong2024ampkregulatesthe pages 58-62): C Wong. Ampk regulates the release of exosomal mirnas to facilitate neuron-germ line communication during the dauer stage. Unknown journal, 2024.

3. (wong2024ampkregulatesthe pages 62-66): C Wong. Ampk regulates the release of exosomal mirnas to facilitate neuron-germ line communication during the dauer stage. Unknown journal, 2024.

4. (mulligan2023regulationofendosomal pages 2-4): Ryan J. Mulligan and Bettina Winckler. Regulation of endosomal trafficking by rab7 and its effectors in neurons: clues from charcot–marie–tooth 2b disease. Biomolecules, 13:1399, Sep 2023. URL: https://doi.org/10.3390/biom13091399, doi:10.3390/biom13091399. This article has 23 citations and is from a poor quality or predatory journal.

5. (valencia2024rab7palmitoylationbya pages 51-54): LD Tejeda Valencia. Rab7 palmitoylation by zdhhc11 and phosphorylation by nek7 as modulators of endo-lysosomal trafficking in batten disease. Unknown journal, 2024.

6. (valencia2024rab7palmitoylationby pages 51-54): LD Tejeda Valencia. Rab7 palmitoylation by zdhhc11 and phosphorylation by nek7 as modulators of endo-lysosomal trafficking in batten disease. Unknown journal, 2024.

7. (cai2021nrbf2isa pages 1-3): Cui-Zan Cai, Chuanbin Yang, Xu-Xu Zhuang, Ning-Ning Yuan, Ming-Yue Wu, Jie-Qiong Tan, Ju-Xian Song, King-Ho Cheung, Huanxing Su, Yi-Tao Wang, Bei-Sha Tang, Christian Behrends, Siva Sundara Kumar Durairajan, Zhenyu Yue, Min Li, and Jia-Hong Lu. Nrbf2 is a rab7 effector required for autophagosome maturation and mediates the association of app-ctfs with active form of rab7 for degradation. Autophagy, 17:1112-1130, Jun 2021. URL: https://doi.org/10.1080/15548627.2020.1760623, doi:10.1080/15548627.2020.1760623. This article has 54 citations and is from a domain leading peer-reviewed journal.

8. (mulligan2024collapseoflate pages 1-4): Ryan J. Mulligan, Magdalena M. Magaj, Laura Digilio, Stefanie Redemann, Chan Choo Yap, and Bettina Winckler. Collapse of late endosomal ph elicits a rapid rab7 response via the v-atpase and rilp. Journal of Cell Science, May 2024. URL: https://doi.org/10.1242/jcs.261765, doi:10.1242/jcs.261765. This article has 13 citations and is from a domain leading peer-reviewed journal.

Citations

1. borchers2023regulatorysitesin pages 1-2
2. mulligan2023regulationofendosomal pages 2-4
3. wong2024ampkregulatesthe pages 62-66
4. mulligan2024collapseoflate pages 1-4
5. wong2024ampkregulatesthe pages 58-62
6. https://doi.org/10.1073/pnas.2303750120
7. https://doi.org/10.3390/biom13091399
8. https://doi.org/10.1080/15548627.2020.1760623
9. https://doi.org/10.1242/jcs.261765
10. https://doi.org/10.1073/pnas.2303750120,
11. https://doi.org/10.3390/biom13091399,
12. https://doi.org/10.1080/15548627.2020.1760623,
13. https://doi.org/10.1242/jcs.261765,

Introduction

RAB7A (Ras-related protein Rab-7a) is a human gene encoding a small GTP-binding protein of the Rab family, part of the Ras superfamily of regulatory GTPases (www.ncbi.nlm.nih.gov). The protein, often simply called Rab7, acts as a molecular switch cycling between an active GTP-bound state and an inactive GDP-bound state. Rab7A is ubiquitously expressed in human tissues (for example, its mRNA is abundantly present in brain and adipose with RPKM ~100) (www.ncbi.nlm.nih.gov), consistent with a fundamental housekeeping role in cells. It localizes primarily to the cytosolic face of late endosomes and lysosomes, where it directs vesicular traffic from early endosomes to late endosomal compartments (www.nature.com) (www.nature.com). In effect, Rab7A is often described as a master regulator of endosome maturation and transport to lysosomes (pubmed.ncbi.nlm.nih.gov). This central role underlies its involvement in critical processes such as degradation of internalized proteins, recycling of membrane components, and autophagy. Below, we discuss the structure and mechanism of Rab7A, its functions in cellular pathways, subcellular localization and regulation, and its significance in health and disease, incorporating recent research findings (primarily from 2023–2024) and expert analyses.

Rab7A as a Small GTPase: Structure and Molecular Mechanism

Rab7A belongs to the small GTPase family, proteins that function as molecular switches to regulate diverse cellular processes. Like other Rab GTPases, Rab7A consists of about 200 amino acids forming a conserved GTP-binding domain (with characteristic P-loop, switch I and II motifs) that binds and hydrolyzes GTP (go.drugbank.com) (go.drugbank.com). The protein is anchored to endosomal and lysosomal membranes via post-translational prenylation at its C-terminus, allowing it to cycle between membrane-bound and cytosolic states depending on its nucleotide-bound form (www.nature.com). In the GTP-bound (active) state, Rab7A undergoes a conformational change in its switch regions enabling it to recruit a variety of effector proteins. Upon GTP hydrolysis (GDP-bound state), it releases from membranes and inactivates, ceasing effector interactions (pmc.ncbi.nlm.nih.gov). This GTP/GDP cycle is tightly regulated by accessory proteins: guanine nucleotide exchange factors (GEFs) catalyze the exchange of GDP for GTP to activate Rab7A, whereas GTPase-activating proteins (GAPs) accelerate GTP hydrolysis to inactivate Rab7A (pmc.ncbi.nlm.nih.gov). For example, the heterodimeric complex Mon1–Ccz1 serves as a GEF specific for Rab7 on endosomal membranes, ensuring Rab7A is activated at the correct time and place during endosome maturation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Conversely, several TBC-domain containing proteins function as Rab7A GAPs to terminate its activity, and their specificity is generally determined empirically given the large number of Rabs and GAPs in cells (pmc.ncbi.nlm.nih.gov). Through this regulated switch mechanism, Rab7A acts as an on-demand recruiter of downstream effectors that execute membrane trafficking events.

When Rab7A is in its GTP-bound active form, it interacts with multiple effector proteins that mediate subsequent steps in vesicle transport and fusion. Notable effectors of Rab7A include the HOPS complex (a multi-subunit tethering complex required for late endosome–lysosome fusion), the retromer complex (which recycles specific cargos from endosomes to the Golgi), and Rab-interacting lysosomal protein (RILP) (pmc.ncbi.nlm.nih.gov). RILP is particularly important as it links Rab7A-positive vesicles to the cytoskeletal motor machinery: RILP directly recruits the dynein–dynactin motor complex by binding to dynactin’s p150^Glued subunit (pmc.ncbi.nlm.nih.gov). Through RILP, active Rab7A “hitches” late endosomes and lysosomes onto dynein motors, driving their transport along microtubules toward the perinuclear region (pubmed.ncbi.nlm.nih.gov). This activity is critical for moving vesicles centripetally and positioning lysosomes within the cell. Additionally, other effectors like FYCO1 bind Rab7A to mediate transport in the opposite direction (toward microtubule plus ends), balancing organelle positioning between the cell center and periphery (pmc.ncbi.nlm.nih.gov). Thus, by cycling between states and engaging different effectors, Rab7A orchestrates both the movement of endosomal vesicles and their readiness for fusion or cargo sorting.

Role in Endosomal Trafficking and Receptor Degradation

Endosome Maturation: Rab7A’s most well-established function is guiding the maturation of endosomes and their progression into degradative compartments. It is predominantly associated with late endosomes and lysosomes, and is essential for the transition from early endosomes (marked by Rab5) to late endosomes (pubmed.ncbi.nlm.nih.gov) (www.nature.com). During this progression, Rab7A is recruited to maturing endosomal membranes (as Rab5 dissociates) in a process often termed “Rab conversion,” which marks the commitment of an endosome to the late endocytic pathway. Rab7A then facilitates the formation of multivesicular bodies and the movement of these late endosomes along microtubules via dynein, bringing them into proximity with perinuclear lysosomes (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). A 2022 cell-biological study highlighted that Rab7 is required not only for the motility of endosomes but also for their maturation into fusion-competent organelles: experimentally disrupting dynein–dynactin or Rab7 function caused late endosomes to accumulate with excess Rab7 and delayed their fusion with lysosomes, thereby blocking cargo degradation (pubmed.ncbi.nlm.nih.gov). In summary, Rab7A acts as a switch that triggers the late-stage maturation of endosomes and their convergence with lysosomes.

Cargo Transport and Degradation: Once active on a late endosome, Rab7A directly contributes to the degradation of endocytic cargo by enabling fusion with lysosomes. It plays a fundamental role in the trafficking and down-regulation of signaling receptors and other proteins internalized at the cell surface. For instance, the epidermal growth factor receptor (EGFR) must be transported to lysosomes for signal termination and degradation, a process that requires functional Rab7A (www.nature.com). If Rab7A activity is impaired (for example, by dominant-negative mutants or gene knockdown), cargo such as EGFR or low-density lipoprotein (LDL) receptors accumulate in swollen late endosomal vacuoles and fail to be degraded, underscoring Rab7A’s necessity for the endosome-lysosome fusion step (www.nature.com) (pubmed.ncbi.nlm.nih.gov). Rab7A also participates in the turnover of adhesion molecules and other plasma membrane proteins by routing them into lysosomal pathways (www.nature.com). In addition to promoting degradation, Rab7A coordinates with recycling pathways: through effectors like the retromer complex, Rab7A helps sort certain receptors (for example, the cation-independent mannose-6-phosphate receptor or trophic factor receptors) away from degradation and toward recycling routes (pubmed.ncbi.nlm.nih.gov) (www.nature.com). In neurons, this sorting function is particularly important for long-range signaling endosomes – for example, Rab7A helps regulate the retrograde transport of nerve growth factor (NGF)–TrkA receptor complexes from the axon terminal to the cell soma, ensuring proper signal propagation for neuron survival (pubmed.ncbi.nlm.nih.gov). Taken together, Rab7A is central to determining the fate of endocytosed proteins, balancing whether they will be recycled or sent for destruction, and thereby maintaining cellular proteostasis (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov).

Lysosome Biogenesis and Positioning: Beyond cargo sorting, active Rab7A influences the biology of lysosomes themselves. It has been shown to contribute to lysosome biogenesis and the maintenance of lysosomal morphology (www.nature.com). Rab7A-positive late endosomes often fuse with pre-existing lysosomes, delivering membrane and content that can enlarge or replenish lysosomal compartments. In addition, by controlling motor attachment via RILP (dynein-based inward transport) and other effectors, Rab7A impacts lysosome positioning within the cell (www.nature.com). Perinuclear positioning of lysosomes, driven by Rab7A–RILP–dynein, can affect cellular processes like nutrient signaling and degradative capacity, while release of Rab7A activity (or engagement of opposite motors) allows lysosomes to scatter toward the cell periphery when needed. Thus, Rab7A not only guides vesicles to lysosomes but also helps organize the lysosomal compartment’s distribution and dynamics in the cell.

Role in Autophagy and Organelle Dynamics

Beyond classical endocytosis, Rab7A is a crucial player in macroautophagy – the process by which cells degrade cytosolic components and organelles via autophagosomes and lysosomes. Autophagosomes are double-membraned vesicles that form around cargo destined for degradation, and they must fuse with lysosomes to become autolysosomes where hydrolysis occurs. Rab7A is required for this autophagosome–lysosome fusion step, acting on the autophagosome membrane similarly to how it operates on late endosomes (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). During autophagy, Rab7A is recruited to autophagosome membranes after their formation, and it works in concert with tethering complexes like HOPS and membrane fusion SNARE proteins to promote the autophagosome’s merger with a Rab7-positive lysosome (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). Experimental evidence shows that loss of Rab7A function can cause an accumulation of incomplete autophagic vacuoles – autophagosomes that have not fused with lysosomes – leading to impaired degradation of autophagy substrates. For example, a study on neuronal cells demonstrated that constitutive activation of Rab7 (simulating a state where Rab7 cannot turn off) actually inhibited autophagic flux, likely by tethering lysosomes in an arrested state (pubmed.ncbi.nlm.nih.gov). This finding highlights that Rab7A’s GTP/GDP cycling is essential: the protein must be turned on to initiate fusion, but later turned off to allow the final maturation and content degradation to proceed (pubmed.ncbi.nlm.nih.gov). In summary, Rab7A is indispensable for the late stage of autophagy, ensuring autophagosomes fuse with lysosomes so that cellular waste and damaged organelles are broken down.

Rab7A’s role in autophagy also extends to organelle quality control, notably in mitophagy – the selective autophagic removal of mitochondria. Rab7A has been implicated in the formation of mitophagosomes and their fusion with lysosomes, facilitating the clearance of dysfunctional mitochondria (pubmed.ncbi.nlm.nih.gov). Additionally, Rab7A helps regulate contacts between lysosomes and mitochondria. These inter-organelle contact sites have emerged as important hubs for exchanging signals and lipids; Rab7A localizes to mitochondria–lysosome contact points and evidence suggests it can trigger contact formation or dissociation via its GTPase activity (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). A recent study (2023) demonstrated that Rab7A-mediated GTP hydrolysis is required to untether mitochondria–lysosome contacts, essentially acting as a timer for how long the two organelles stay docked (pmc.ncbi.nlm.nih.gov). In healthy cells, transient contacts allow lysosomes to help position and divide mitochondria, a process necessary for proper mitochondrial fission and distribution (pmc.ncbi.nlm.nih.gov). Rab7A’s involvement in this process was dramatically illustrated by disease-associated mutants (see below): a Charcot–Marie–Tooth neuropathy-causing Rab7A mutant (V162M) was shown to have reduced GTPase activity, causing prolonged and excessive tethering of mitochondria to lysosomes in neurons (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This aberrant persistence of contacts led to downstream defects in mitochondrial dynamics and function. Thus, Rab7A is emerging not only as a facilitator of vesicle fusion but also as a regulator of organelle communication and dynamics within cells. Its activity finely balances events like autophagosome clearance and mitochondrial fission, underscoring how Rab7A links the endolysosomal system with other cellular homeostasis mechanisms.

Subcellular Localization and Regulation

Rab7A is predominantly localized to late endosomes, multivesicular bodies, and lysosomes on the cytoplasmic side of their limiting membranes (www.nature.com). It achieves membrane attachment through two C-terminal geranylgeranyl lipid modifications, which anchor the protein into the lipid bilayer when it is in its active conformation. Localized activation of Rab7A is crucial; the cell exerts tight spatial control over where Rab7A switches “on.” As mentioned, the Mon1–Ccz1 complex activates Rab7A specifically on late endosomal/autophagosomal membranes, and not on earlier endosomes (pmc.ncbi.nlm.nih.gov). This ensures Rab7A is mainly present on more mature vesicles. Conversely, when a Rab7A-bearing vesicle fuses with a lysosome or when its task is completed, a GAP triggers GTP hydrolysis, causing Rab7A to dissociate into the cytosol. GDP-bound Rab7A is kept soluble in the cytoplasm by forming a complex with GDP-dissociation inhibitor (GDI), which escorts Rab proteins in their inactive state. GDI recycling of Rab7A prevents premature re-association with membranes until a new GEF (like Mon1–Ccz1) inserts Rab7A onto a target organelle (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Through this cycle, Rab7A can be repeatedly used and targeted to the correct membranes in the cell.

Multiple layers of regulation modulate Rab7A activity. In addition to GEFs/GAPs, there are upstream signaling pathways and protein modifications that influence Rab7A function. For instance, some protein kinases can phosphorylate Rab7 or its effectors to alter their activity. A recent study identified a “Rab7A phosphoswitch” mechanism involving a kinase (LRRK1) that phosphorylates the Rab7A-specific GAP TBC1D2/Armus, thereby modulating Rab7A activity during growth factor signaling (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Moreover, lipid environment plays a role: late endosomal membranes enriched in phosphatidylinositol-3-phosphate (PI3P) help recruit Mon1–Ccz1, linking Rab7A activation to the presence of PI3P on mature endosomes (pmc.ncbi.nlm.nih.gov). This coordination means that only endosomes that have acquired the correct lipid and protein markers (signifying maturity) will activate Rab7A. There is also interplay with other Rab proteins – for example, the prior Rab5 on early endosomes must be inactivated/removed (a process aided by Rab7A’s GEF Mon1-Ccz1 and a Rab5 GAP) to allow Rab7A to take over; this sequential handoff is a hallmark of endosomal maturation (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). In summary, Rab7A’s localization to late endosomal and lysosomal membranes, and its timely activation there, are achieved by dedicated regulatory factors that integrate signals about organelle identity and cellular needs.

Biological Pathways and Interactions

Rab7A’s activity touches several biological pathways and cellular functions. In the endocytic pathway, as detailed, it governs the fate of internalized material by facilitating degradation versus recycling decisions. Through this role, Rab7A indirectly influences signaling pathways: for example, dampening of growth factor signaling occurs when Rab7A directs activated receptors to lysosomes for down-regulation (www.nature.com). In immune cells, Rab7A is required for phagosome maturation – the process by which phagocytosed particles (like bacteria) are delivered to lysosomes (forming phagolysosomes) for destruction (www.nature.com). Rab7A also interfaces with the retromer pathway (retrograde transport to the Golgi). By interacting with retromer components (such as VPS35), Rab7A helps retrieve certain receptors and hydrolases from late endosomes back to the trans-Golgi network (pubmed.ncbi.nlm.nih.gov). This step is crucial for recycling enzymes (like lysosomal hydrolases tagged with mannose-6-phosphate) and sustaining lysosome function.

Intriguingly, Rab7A has been implicated in cell signaling beyond its trafficking duties. A recent oncology study found that Rab7A in B-lymphocytes is involved in assembling intracellular signaling complexes that activate NF-κB, a key transcription factor in immune responses (pubmed.ncbi.nlm.nih.gov). Upon B-cell stimulation, Rab7-positive endosomal membranes can serve as platforms (often called “signalosomes”) where signaling molecules gather, and Rab7A is needed for their proper formation and function (pubmed.ncbi.nlm.nih.gov). This indicates Rab7A can have a signaling facilitator role, at least in specific cell types, linking endosomal trafficking with downstream gene activation. Additionally, Rab7A intersects with metabolic pathways; for instance, in conditions of cholesterol overload (such as in Niemann-Pick type C disease where cholesterol transport out of lysosomes is impaired), Rab7A has been shown to exacerbate or alleviate lipid accumulation depending on its activity status (www.nature.com). Rab7A likely promotes the clearance or movement of cholesterol-laden endosomes, as Rab7A knockdown in NPC disease models led to worsened cholesterol storage (www.nature.com). These examples illustrate that Rab7A’s influence extends beyond simple vesicle transport to broader cellular physiology, affecting signaling cascades, immune functions, and metabolic homeostasis.

Clinical Significance and Disease Associations

Given its central role in vesicle trafficking, it is not surprising that RAB7A has been linked to human diseases when its function is perturbed. The most direct connection is seen in a dominantly inherited peripheral neuropathy known as Charcot–Marie–Tooth type 2B (CMT2B). Missense mutations in the RAB7A gene (such as V162M, L129F, and K157N among others) cause this disease (pmc.ncbi.nlm.nih.gov). CMT2B is characterized by progressive degeneration of peripheral sensory neurons, often leading to sensory loss and ulcerations in the extremities (pmc.ncbi.nlm.nih.gov). At the molecular level, these disease-causing mutations typically affect Rab7A’s GTPase cycle – several CMT2B mutations result in a protein with impaired GTP hydrolysis, meaning Rab7A remains abnormally locked in its active state (pmc.ncbi.nlm.nih.gov). This hyperactive Rab7A causes dysfunction in endosomal trafficking: neurons from patients (or animal models) show enlarged, stalled endolysosomal structures and defects in axonal transport of cargo (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). A prevailing hypothesis is that CMT2B mutants disrupt the normal endocytic trafficking of neurotrophin receptors critical for neuron survival. In support of this, studies have shown that Rab7A CMT2B mutants misregulate the retrograde transport of NGF/TrkA signaling endosomes in neurons, leading to reduced trophic support for distal axons (pubmed.ncbi.nlm.nih.gov). Furthermore, as noted above, mutant Rab7A’s inability to properly release organelle contact sites (due to stalled GTP hydrolysis) can lead to organelle dysregulation – the 2023 study by Wong et al. demonstrated that a CMT2B Rab7A mutation prolonged mitochondria–lysosome contacts and caused secondary mitochondrial fragmentation in peripheral neurons (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These cellular defects ultimately manifest as the axonal degeneration and sensory neuropathy observed clinically. While CMT2B is rare, it underscores the importance of Rab7A’s precise regulation in neuronal health. Notably, because CMT2B mutations confer a gain-of-function (hyperactive Rab7A), therapeutic strategies are being explored to normalize Rab7A activity in patients – for example, drugs that could enhance Rab7A’s GTP hydrolysis or disrupt its prolonged actions are of research interest.

Rab7A has also been associated with infectious disease processes. Certain pathogens hijack or avoid Rab7A-mediated pathways to enhance their survival inside host cells. A classic example is the VacA cytotoxin of Helicobacter pylori, which causes host-cell vacuolation; Rab7A is required for VacA-induced vacuole formation, likely because the toxin co-opts the late endosomal compartment (where Rab7 resides) to create large vacuoles (www.ncbi.nlm.nih.gov). Additionally, intracellular bacteria such as Salmonella and Legionella produce effector proteins that target Rab7. Salmonella SopD2, for instance, can bind to endosomal membranes and is thought to interfere with Rab7 recruitment or function, thereby delaying phagolysosome formation (pmc.ncbi.nlm.nih.gov). Legionella pneumophila secretes factors that prevent Rab7A from associating with their containing vacuole, allowing the pathogen to avoid lysosomal destruction (pmc.ncbi.nlm.nih.gov). These interactions highlight Rab7A as a battleground during host-pathogen interactions: its normal role would be to deliver bacteria to degradative lysosomes, and pathogens that evolve ways to circumvent Rab7A can persist inside cells. Understanding these mechanisms is driving interest in Rab7A as a potential target to bolster host cell clearance of pathogens or to prevent toxin-induced damage.

Rab7A dysregulation has implications in cancer biology as well. Altered expression of RAB7A is observed in various cancers, and it can influence tumor cell behavior. In some contexts, Rab7A appears to promote oncogenic processes: for example, gastric cancer tissues have been found to overexpress Rab7 relative to normal tissue, and higher Rab7 levels correlated with more lymph node metastasis and poorer patient prognosis (pmc.ncbi.nlm.nih.gov). Functionally, increasing Rab7A in gastric cancer cell lines enhanced their proliferation, invasion, and migration, partly via activating the PI3K–AKT signaling pathway (pmc.ncbi.nlm.nih.gov). Similarly, in vivo and in vitro studies of melanoma have shown that Rab7A supports tumor progression. High Rab7A expression is associated with a greater risk of metastasis in melanoma patients (www.nature.com) (www.nature.com), and melanoma cell lines express Rab7A at significantly higher levels than normal melanocytes (www.nature.com) (www.nature.com). Rab7A in melanoma was recently found to interact functionally with a lysosomal cation channel (TPC2), enhancing TPC2 activity which in turn stabilizes the pro-tumorigenic factor MITF; this axis (Rab7A–TPC2–MITF) promotes melanoma cell growth and invasion (www.nature.com) (www.nature.com). On the other hand, there are reports in certain cancer types that suppressing Rab7A can impede tumor growth: for example, silencing RAB7A in breast cancer cells reduced their proliferation and ability to form tumors in mice (www.nature.com). These findings suggest Rab7A’s role in cancer may be context-dependent but often crucial – it can modulate signaling pathways (like AKT or β-catenin) and affect the turnover of proteins that restrain or promote cell motility and survival. Clinically, RAB7A expression is being evaluated as a prognostic biomarker in some cancers (e.g., high RAB7A portending worse outcomes in gastric and liver cancers) (www.nature.com).

The broad involvement of Rab7A in disease has motivated interest in it as a therapeutic target. One promising avenue is the development of small molecules that modulate Rab7A activity. Researchers have identified compounds that can inhibit Rab7A – for instance, CID1067700 is a selective small-molecule Rab7 inhibitor that was shown to arrest the growth of B-cell lymphomas (pubmed.ncbi.nlm.nih.gov). In experimental models, treating lymphoma cells with this Rab7 inhibitor caused dose-dependent suppression of cell proliferation and induced cell death, and it also reduced tumor growth in mice xenografts (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). These effects are likely due to the compound disrupting Rab7A’s function in endosomal signaling (such as NF-κB activation) and nutrient trafficking, which lymphoma cells rely on (pubmed.ncbi.nlm.nih.gov). Moreover, high RAB7A expression was observed in aggressive lymphomas and linked to poorer patient survival, supporting the idea that targeting Rab7A could be beneficial (pubmed.ncbi.nlm.nih.gov). Beyond cancer, therapeutic modulation of Rab7A is being considered in contexts like neurodegeneration and infectious disease. While no Rab7-specific drugs are in clinical use yet, these studies provide a proof-of-concept that Rab7A’s activity is druggable and that altering its function can have tangible effects on disease outcomes. It is a vivid example of how understanding a fundamental cell biology protein can open up new strategies for intervention in disease pathways.

Recent Developments (2023–2024)

Neuropathy and Organelle Contacts: A significant recent advancement in Rab7A research is the deeper understanding of how Rab7A mutations cause neuropathy via organelle contact site dysregulation. In PNAS (2023), Wong et al. investigated peripheral neurons from a CMT2B mouse model carrying a Rab7a mutation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). They discovered that mutant Rab7A leads to prolonged mitochondria–lysosome contacts in axons, due to the mutant’s inability to hydrolyze GTP and disengage from lysosomal membranes (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These extended contacts were not merely a curiosity; they resulted in downstream abnormalities in mitochondrial movement and function, contributing to axonal degeneration and sensory loss in the mice (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This work highlighted a new pathway of disease: beyond trafficking defects, CMT2B may be a disorder of organelle tethering, with Rab7A hyperactivity “freezing” critical organelle dynamics. It underscores how precisely balanced Rab7A activity must be for neuronal health. The study’s insights could help direct therapies that specifically aim to restore normal contact dynamics (for example, by enhancing the release of Rab7A from lysosomes).

Rab7A in Cancer Progression: In the cancer research arena, 2023 saw new findings about Rab7A’s role in melanoma. In Nature Communications (2024), Garg et al. demonstrated that Rab7a acts as an enhancer of TPC2 (Two-Pore Channel 2) activity, forming a functional unit that drives melanoma cell proliferation and metastasis (www.nature.com) (www.nature.com). Mechanistically, Rab7a was found to physically interact with TPC2 on endolysosomal membranes and increase its calcium-release channel activity (www.nature.com) (www.nature.com). This heightened TPC2 activity led to downstream stabilization of β-catenin and the melanoma oncogene MITF, via altered degradation of GSK3β in lysosomes (www.nature.com) (www.nature.com). Functionally, the presence of Rab7a was shown to be critical: the protumor effects of TPC2 (such as enhanced invasion and growth) were abolished if Rab7a was absent or inhibited (www.nature.com) (www.nature.com). Notably, applying a Rab7A inhibitor reversed TPC2’s effects on melanoma cells, hinting at therapeutic potential (www.nature.com) (www.nature.com). This research not only elaborates a novel Rab7A-mediated signaling axis in cancer (tying together Rab7A, ion channels, and canonical growth pathways), but also reinforces that high Rab7A levels in tumors are functionally important and not just a bystander effect. Concordantly, other recent studies (2021–2023) reported that high RAB7A expression promotes tumor aggressiveness in gastric, liver, and breast cancers (www.nature.com), making Rab7A a topic of interest for new cancer prognostic markers and targeted therapies.

Autophagy and Aging Research: Emerging work in 2023 has also examined Rab7A in the context of organismal aging and neurodegeneration. For example, an experimental study in Drosophila (2023) screened various small GTPases for their effects on neuronal autophagy and lifespan (pubmed.ncbi.nlm.nih.gov). Intriguingly, it found that constitutively active Rab7 (a GTP-locked form) in neurons led to a blockage in autophagic degradation and significantly shortened the flies’ lifespan (pubmed.ncbi.nlm.nih.gov). This result aligns with the idea that Rab7A’s activity must turn off at the right time; a Rab7A that cannot turn off effectively jams the autophagy process (by perhaps over-tethering lysosomes or preventing cargo turnover). In contrast, boosting other GTPases like Rab2 or Arl8 enhanced autophagy and longevity in the same model (pubmed.ncbi.nlm.nih.gov). These findings provide a nuanced view: while Rab7A is necessary for autophagosome-lysosome fusion, too much Rab7A activity is detrimental. For neurodegenerative diseases characterized by autophagy defects, this suggests that interventions might need to modulate Rab7A rather than simply activate it. In fact, a balanced upregulation of lysosomal clearance (perhaps via other effectors or temporal control of Rab7A) could be more beneficial than constitutive Rab7A activation.

Therapeutic Targeting: On the therapeutic front, the concept of targeting Rab7A is gaining traction. A recent study in Frontiers in Oncology (2024) reported on a first-in-class Rab7A inhibitor, with evidence that inhibiting Rab7A can induce apoptosis in lymphoma cells and improve survival in animal models (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). This small molecule (CID1067700) shows that drugging the Rab7 cycle is feasible. Since Rab7A is a regulatory protein, complete inhibition in normal cells might be harmful, but cancer cells often appear more dependent on Rab7A for their heightened metabolic and signaling needs (pubmed.ncbi.nlm.nih.gov). Ongoing research is evaluating how selectively interfering with Rab7A or its effectors can be used to treat diseases such as cancer or CMT2B neuropathy, with strategies ranging from small molecules and peptides to gene therapy.

Conclusion

RAB7A encodes a pivotal regulator of the late endocytic pathway, functioning at the crossroads of vesicular trafficking, degradation, and autophagy. As a small GTPase, Rab7A’s ability to switch between active and inactive states allows it to control when and where vesicles move, fuse, or interact with other organelles. It ensures that cellular cargo—ranging from growth factor receptors to pathogenic bacteria to worn-out organelles—is delivered into the lysosomal degradation route at the proper time. Rab7A’s influence extends into essential cellular activities: it governs receptor down-regulation, nutrient and signaling receptor recycling, lysosome biogenesis, and autophagosome clearance. Its importance is underscored by the myriad of interactions it has with effector proteins (HOPS, retromer, motor adaptors, etc.) and by the consequences observed when Rab7A malfunctions.

Modern research has illuminated that Rab7A is not only a trafficking protein but also a node that connects to disease pathways. Mutations in RAB7A leading to neuropathy demonstrate how sensitive neuronal health is to endolysosomal balance. Cancer studies reveal Rab7A as a facilitator of tumor progression in certain contexts, making it a potential biomarker and target for therapy. Even in infectious disease and aging, Rab7A’s activity (or lack thereof) can tip the scales in cellular outcomes. Expert reviews and recent studies consistently refer to Rab7A as a central coordinator of late endosome and lysosome function (pubmed.ncbi.nlm.nih.gov) (www.nature.com), reflecting a broad consensus in the field about its critical role.

Going forward, the challenge and opportunity lie in translating this rich understanding of Rab7A biology into medical advances. Targeted manipulation of Rab7A or its pathways could correct specific cellular defects – such as enhancing autophagic flux in neurodegeneration or restraining metastasis in cancer. Any such interventions will require finesse, given the essential nature of Rab7A in normal physiology. Nonetheless, the continued unraveling of Rab7A’s regulatory networks and its involvement in human disease holds promise for innovative treatments that restore cellular homeostasis by fine-tuning the cell’s own trafficking machinery.

References: The information above was compiled from recent authoritative sources, including primary research articles and reviews from 2018–2024. Key sources include Frontiers in Cell and Developmental Biology (2018) (pmc.ncbi.nlm.nih.gov), Journal of Neuroscience (2022) (pubmed.ncbi.nlm.nih.gov), Proceedings of the National Academy of Sciences (2023) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov), Nature Communications (2024) (www.nature.com) (www.nature.com), and other peer-reviewed publications as cited throughout. Each citation in the text corresponds to the specific source supporting the preceding statement, with publication details and URLs provided for verification.

Citations

1. AnnotationURLCitation(end_index=356, start_index=174, title='RAB7A RAB7A, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=7879#:~:text=RAB%20family%20members%20are%20small%2C,provided%20by%20RefSeq%2C%20Jul%202008')
2. AnnotationURLCitation(end_index=817, start_index=630, title='RAB7A RAB7A, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=7879#:~:text=Expression%20Ubiquitous%20expression%20in%20brain,25%20other%20tissues%20See%20more')
3. AnnotationURLCitation(end_index=1166, start_index=1042, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=localized%20to%20the%20cytoplasmic%20face,and')
4. AnnotationURLCitation(end_index=1351, start_index=1167, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
5. AnnotationURLCitation(end_index=1632, start_index=1463, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative')
6. AnnotationURLCitation(end_index=2559, start_index=2437, title='Ras-related protein Rab-7a | DrugBank', type='url_citation', url='https://go.drugbank.com/polypeptides/P51149#:~:text=Ras,transport%20%2F%20epidermal%20growth%20factor')
7. AnnotationURLCitation(end_index=2679, start_index=2560, title='Ras-related protein Rab-7a | DrugBank', type='url_citation', url='https://go.drugbank.com/polypeptides/P51149#:~:text=,transport%20%2F%20epidermal%20growth%20factor')
8. AnnotationURLCitation(end_index=3024, start_index=2900, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=localized%20to%20the%20cytoplasmic%20face,and')
9. AnnotationURLCitation(end_index=3451, start_index=3289, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=the%20sites%20of%20mitochondrial%20fission,review%20will%20discuss%20the%20GEF')
10. AnnotationURLCitation(end_index=3866, start_index=3703, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=retromer%20complexes%20and%20the%20dynactin,review%20will%20discuss%20the%20GEF')
11. AnnotationURLCitation(end_index=4231, start_index=4060, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Drosophila%2C%20MTM1%20is%20required%20for,in%20endosome%20maturation%20and%20autophagy')
12. AnnotationURLCitation(end_index=4373, start_index=4232, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Binding%20of%20Mon1,activates%20the%20GEF%20activity%20of')
13. AnnotationURLCitation(end_index=4732, start_index=4583, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=GTPase,TBC%20domains%E2%80%99%20specificity%20empirically%2C%20by')
14. AnnotationURLCitation(end_index=5451, start_index=5291, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Rab7%20%E2%80%93%20or%20in%20yeast%2C,GAPs%29%20boost%20Rab7%E2%80%99s%20GTP')
15. AnnotationURLCitation(end_index=5769, start_index=5658, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=lysosomal%20protein%20,2001')
16. AnnotationURLCitation(end_index=6096, start_index=5930, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=directional%20retrograde%20transport%20in%20dendrites%2C,to%20arrival%20in%20the%20soma')
17. AnnotationURLCitation(end_index=6513, start_index=6402, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=lysosomal%20protein%20,2001')
18. AnnotationURLCitation(end_index=7237, start_index=7064, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=compartments%2C%20which%20are%20linked%20maturationally,E18%20rat%20hippocampal%20neurons%20of')
19. AnnotationURLCitation(end_index=7422, start_index=7238, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
20. AnnotationURLCitation(end_index=7998, start_index=7829, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative')
21. AnnotationURLCitation(end_index=8165, start_index=7999, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=directional%20retrograde%20transport%20in%20dendrites%2C,to%20arrival%20in%20the%20soma')
22. AnnotationURLCitation(end_index=8672, start_index=8521, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=flux%20of%20late%20endosomes,dependent%20dynein%2Fdynactin%20recruitment')
23. AnnotationURLCitation(end_index=9469, start_index=9285, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
24. AnnotationURLCitation(end_index=9950, start_index=9766, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
25. AnnotationURLCitation(end_index=10120, start_index=9951, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative')
26. AnnotationURLCitation(end_index=10443, start_index=10259, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
27. AnnotationURLCitation(end_index=10895, start_index=10751, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=leading%20to%20an%20ulcero,We%20further%20discuss%20the%20current')
28. AnnotationURLCitation(end_index=11080, start_index=10896, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
29. AnnotationURLCitation(end_index=11538, start_index=11387, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=differentiated%20cells.%20In%20Charcot,largest%20cells%20in%20the%20body')
30. AnnotationURLCitation(end_index=11910, start_index=11733, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=Intracellular%20endosomal%20trafficking%20controls%20the,such%20as%20coordination%20of%20recycling')
31. AnnotationURLCitation(end_index=12080, start_index=11911, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=activity%20of%20small%20GTPases%2C%20including,their%20long%20lifespans%20as%20postmitotic')
32. AnnotationURLCitation(end_index=12476, start_index=12306, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=from%20early%20endosomes%20,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
33. AnnotationURLCitation(end_index=12962, start_index=12792, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=from%20early%20endosomes%20,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
34. AnnotationURLCitation(end_index=14048, start_index=13938, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=Drosophila%20melanogaster,Nerve')
35. AnnotationURLCitation(end_index=14203, start_index=14049, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=HOPS%20complex%20forms%20a%20bridge,to%20degrade%20the%20autophagic%20cargo')
36. AnnotationURLCitation(end_index=14620, start_index=14454, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=enzymatic%20degradation%20happens,lifespan%2C%20climbing%20ability%2C%20and%20autophagy')
37. AnnotationURLCitation(end_index=14775, start_index=14621, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=HOPS%20complex%20forms%20a%20bridge,to%20degrade%20the%20autophagic%20cargo')
38. AnnotationURLCitation(end_index=15387, start_index=15232, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=of%20these%20genetic%20interventions%20on,CA%20expression%20also%20increases')
39. AnnotationURLCitation(end_index=15758, start_index=15592, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=directional%20retrograde%20transport%20in%20dendrites%2C,to%20arrival%20in%20the%20soma')
40. AnnotationURLCitation(end_index=16380, start_index=16233, title='RAB7A GTPase Is Involved in Mitophagosome Formation and Autophagosome-Lysosome Fusion in N2a Cells Treated with the Prion Protein Fragment 106-126 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/36449254/#:~:text=Lysosome%20Fusion%20in%20N2a%20Cells,we%20show%20that%20RAB7A%2C%20a')
41. AnnotationURLCitation(end_index=16896, start_index=16715, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=match%20at%20L86%20mitochondria%E2%80%93lysosome%20contact,this%20drives%20axonal%20defects%20in')
42. AnnotationURLCitation(end_index=17087, start_index=16897, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in')
43. AnnotationURLCitation(end_index=17472, start_index=17291, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=match%20at%20L86%20mitochondria%E2%80%93lysosome%20contact,this%20drives%20axonal%20defects%20in')
44. AnnotationURLCitation(end_index=17770, start_index=17639, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Rab7%20%E2%80%93%20or%20in%20yeast%2C,Accessory')
45. AnnotationURLCitation(end_index=18227, start_index=18067, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged')
46. AnnotationURLCitation(end_index=18418, start_index=18228, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in')
47. AnnotationURLCitation(end_index=19231, start_index=19047, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
48. AnnotationURLCitation(end_index=19802, start_index=19661, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Binding%20of%20Mon1,activates%20the%20GEF%20activity%20of')
49. AnnotationURLCitation(end_index=20482, start_index=20341, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Binding%20of%20Mon1,activates%20the%20GEF%20activity%20of')
50. AnnotationURLCitation(end_index=20632, start_index=20483, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=GTPase,TBC%20domains%E2%80%99%20specificity%20empirically%2C%20by')
51. AnnotationURLCitation(end_index=21358, start_index=21220, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Armus%20also%20acts%20in%20autophagy,When%20Armus%20is')
52. AnnotationURLCitation(end_index=21526, start_index=21359, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Rab5%20on%20late%20endosomes%2C%20i,functions%20in%20their%20respective%20organisms')
53. AnnotationURLCitation(end_index=21911, start_index=21740, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Drosophila%2C%20MTM1%20is%20required%20for,in%20endosome%20maturation%20and%20autophagy')
54. AnnotationURLCitation(end_index=22500, start_index=22331, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=activity%20of%20small%20GTPases%2C%20including,their%20long%20lifespans%20as%20postmitotic')
55. AnnotationURLCitation(end_index=22669, start_index=22501, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=is%20particularly%20important%20in%20the,Tooth%202B%20disease%20%28CMT2B%29%2C%20familial')
56. AnnotationURLCitation(end_index=23523, start_index=23353, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=from%20early%20endosomes%20,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
57. AnnotationURLCitation(end_index=23885, start_index=23715, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=from%20early%20endosomes%20,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
58. AnnotationURLCitation(end_index=24312, start_index=24139, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=switches%20direct%20activity%20at%20endosomal,Tooth%202B%20disease%20%28CMT2B%29%2C%20familial')
59. AnnotationURLCitation(end_index=24880, start_index=24728, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=RAB7%2C%20encoded%20by%20RAB7A%20in,activated%20human%20tonsil%20B%20cells')
60. AnnotationURLCitation(end_index=25240, start_index=25088, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=RAB7%2C%20encoded%20by%20RAB7A%20in,activated%20human%20tonsil%20B%20cells')
61. AnnotationURLCitation(end_index=25865, start_index=25707, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=and%20high%20Rab7a%20expression%20is,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a')
62. AnnotationURLCitation(end_index=26182, start_index=26024, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=and%20high%20Rab7a%20expression%20is,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a')
63. AnnotationURLCitation(end_index=26930, start_index=26814, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=Rab7%20mutations%20,3%E2%80%937')
64. AnnotationURLCitation(end_index=27269, start_index=27079, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=Charcot%E2%80%93Marie%E2%80%93Tooth%20disease%20is%20the%20most,dynamics%20are%20further%20disrupted%20in')
65. AnnotationURLCitation(end_index=27619, start_index=27503, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=Rab7%20mutations%20,3%E2%80%937')
66. AnnotationURLCitation(end_index=27979, start_index=27819, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged')
67. AnnotationURLCitation(end_index=28170, start_index=27980, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in')
68. AnnotationURLCitation(end_index=28663, start_index=28512, title='Regulation of Endosomal Trafficking by Rab7 and Its Effectors in Neurons: Clues from Charcot-Marie-Tooth 2B Disease - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37759799/#:~:text=differentiated%20cells.%20In%20Charcot,largest%20cells%20in%20the%20body')
69. AnnotationURLCitation(end_index=29206, start_index=29018, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=peripheral%20sensory%20neurons%2C%20due%20to,defective%20downstream%20axonal%20mitochondrial%20dynamics')
70. AnnotationURLCitation(end_index=29397, start_index=29207, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in')
71. AnnotationURLCitation(end_index=30530, start_index=30336, title='RAB7A RAB7A, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene?Cmd=DetailsSearch&Db=gene&Term=7879#:~:text=important%20regulators%20of%20vesicular%20transport,provided%20by%20RefSeq%2C%20Jul%202008')
72. AnnotationURLCitation(end_index=30957, start_index=30821, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=and%20multifunctional%20SNARE%20regulators,Autophagy')
73. AnnotationURLCitation(end_index=31215, start_index=31121, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=,Autophagy')
74. AnnotationURLCitation(end_index=32135, start_index=32044, title='Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7339976/#:~:text=Results')
75. AnnotationURLCitation(end_index=32396, start_index=32305, title='Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7339976/#:~:text=Results')
76. AnnotationURLCitation(end_index=32750, start_index=32599, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=match%20at%20L67%20and%20high,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a')
77. AnnotationURLCitation(end_index=32909, start_index=32751, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=and%20high%20Rab7a%20expression%20is,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a')
78. AnnotationURLCitation(end_index=33162, start_index=33004, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=and%20high%20Rab7a%20expression%20is,5%2C9%2C11%2C12%7D.%20Similar%20to%20Rab7a')
79. AnnotationURLCitation(end_index=33317, start_index=33163, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=effect%20of%20Rab7a%20on%20TPC2,of%20both%20proteins%20being%20particularly')
80. AnnotationURLCitation(end_index=33745, start_index=33574, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=small%20GTPase%20Rab7a%20strongly%20enhances,of%20melanoma%20development%20and%20progression')
81. AnnotationURLCitation(end_index=33908, start_index=33746, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=imaging%20experiments%20we%20show%20here,Rab7a%20and%20TPC2%20protein%20interaction')
82. AnnotationURLCitation(end_index=34259, start_index=34134, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=melanoma,growth%20of%20breast%20cancer%20cells')
83. AnnotationURLCitation(end_index=34789, start_index=34664, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=melanoma,growth%20of%20breast%20cancer%20cells')
84. AnnotationURLCitation(end_index=35319, start_index=35166, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=with%20CID1067700%2C%20a%20selective%20small,The%20inhibitory%20effect%20of')
85. AnnotationURLCitation(end_index=35679, start_index=35526, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=with%20CID1067700%2C%20a%20selective%20small,The%20inhibitory%20effect%20of')
86. AnnotationURLCitation(end_index=35797, start_index=35680, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=survival,The%20inhibitory%20effect%20of')
87. AnnotationURLCitation(end_index=36129, start_index=35977, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=RAB7%2C%20encoded%20by%20RAB7A%20in,activated%20human%20tonsil%20B%20cells')
88. AnnotationURLCitation(end_index=36407, start_index=36300, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=inhibitor,derived%20lymphomas')
89. AnnotationURLCitation(end_index=37336, start_index=37239, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=Significance')
90. AnnotationURLCitation(end_index=37497, start_index=37337, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged')
91. AnnotationURLCitation(end_index=37841, start_index=37681, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged')
92. AnnotationURLCitation(end_index=38023, start_index=37842, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=match%20at%20L86%20mitochondria%E2%80%93lysosome%20contact,this%20drives%20axonal%20defects%20in')
93. AnnotationURLCitation(end_index=38413, start_index=38225, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=peripheral%20sensory%20neurons%2C%20due%20to,defective%20downstream%20axonal%20mitochondrial%20dynamics')
94. AnnotationURLCitation(end_index=38604, start_index=38414, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=mitochondria%E2%80%93lysosome%20contact%20untethering%20is%20driven,this%20drives%20axonal%20defects%20in')
95. AnnotationURLCitation(end_index=39548, start_index=39377, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=small%20GTPase%20Rab7a%20strongly%20enhances,of%20melanoma%20development%20and%20progression')
96. AnnotationURLCitation(end_index=39711, start_index=39549, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=imaging%20experiments%20we%20show%20here,Rab7a%20and%20TPC2%20protein%20interaction')
97. AnnotationURLCitation(end_index=40019, start_index=39856, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=In%20proteomics%20studies%20Rab7a%20was,and%20function%2C%20especially%20by%20direct')
98. AnnotationURLCitation(end_index=40182, start_index=40020, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=imaging%20experiments%20we%20show%20here,Rab7a%20and%20TPC2%20protein%20interaction')
99. AnnotationURLCitation(end_index=40463, start_index=40337, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=match%20at%20L110%20activation%20enhanced,Rab7a')
100. AnnotationURLCitation(end_index=40595, start_index=40464, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=activation%20enhanced%20by%20Rab7a%20increases,Rab7a')
101. AnnotationURLCitation(end_index=40946, start_index=40775, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=small%20GTPase%20Rab7a%20strongly%20enhances,of%20melanoma%20development%20and%20progression')
102. AnnotationURLCitation(end_index=41101, start_index=40947, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=effect%20of%20Rab7a%20on%20TPC2,of%20both%20proteins%20being%20particularly')
103. AnnotationURLCitation(end_index=41369, start_index=41215, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=match%20at%20L100%20effect%20of,of%20both%20proteins%20being%20particularly')
104. AnnotationURLCitation(end_index=41524, start_index=41370, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=effect%20of%20Rab7a%20on%20TPC2,of%20both%20proteins%20being%20particularly')
105. AnnotationURLCitation(end_index=42066, start_index=41941, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=melanoma,growth%20of%20breast%20cancer%20cells')
106. AnnotationURLCitation(end_index=42615, start_index=42440, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=autolysosome%20maturation%2C%20and%20among%20these,lifespan%2C%20and%20improves%20the%20climbing')
107. AnnotationURLCitation(end_index=42952, start_index=42797, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=of%20these%20genetic%20interventions%20on,CA%20expression%20also%20increases')
108. AnnotationURLCitation(end_index=43438, start_index=43283, title='Potent New Targets for Autophagy Enhancement to Delay Neuronal Ageing - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/37443788/#:~:text=of%20these%20genetic%20interventions%20on,CA%20expression%20also%20increases')
109. AnnotationURLCitation(end_index=44385, start_index=44232, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=with%20CID1067700%2C%20a%20selective%20small,The%20inhibitory%20effect%20of')
110. AnnotationURLCitation(end_index=44503, start_index=44386, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=survival,The%20inhibitory%20effect%20of')
111. AnnotationURLCitation(end_index=44889, start_index=44782, title='Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/41059303#:~:text=inhibitor,derived%20lymphomas')
112. AnnotationURLCitation(end_index=46814, start_index=46645, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative')
113. AnnotationURLCitation(end_index=46999, start_index=46815, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
114. AnnotationURLCitation(end_index=48100, start_index=47940, title='This Is the End: Regulation of Rab7 Nucleotide Binding in Endolysosomal Trafficking and Autophagy - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC6176412/#:~:text=Rab7%20%E2%80%93%20or%20in%20yeast%2C,GAPs%29%20boost%20Rab7%E2%80%99s%20GTP')
115. AnnotationURLCitation(end_index=48304, start_index=48135, title='Dynein Is Required for Rab7-Dependent Endosome Maturation, Retrograde Dendritic Transport, and Degradation - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/35474277/#:~:text=proteins%20that%20enter%20through%20endocytic,motor%20is%20responsible%20for%20degradative')
116. AnnotationURLCitation(end_index=48523, start_index=48363, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=neurons%20caused%20by%20mutations%20in,mutant%20Rab7%20led%20to%20prolonged')
117. AnnotationURLCitation(end_index=48705, start_index=48524, title='Misregulation of mitochondria–lysosome contact dynamics in Charcot–Marie–Tooth Type 2B disease Rab7 mutant sensory peripheral neurons - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10622892/#:~:text=match%20at%20L86%20mitochondria%E2%80%93lysosome%20contact,this%20drives%20axonal%20defects%20in')
118. AnnotationURLCitation(end_index=48922, start_index=48738, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=known%2C%20Rab7a%20and%20Rab7b%2C%20which,differentiation%2C%20migration%2C%20autophagy%20and%20apoptosis')
119. AnnotationURLCitation(end_index=49085, start_index=48923, title='Rab7a is an enhancer of TPC2 activity regulating melanoma progression through modulation of the GSK3β/β-Catenin/MITF-axis | Nature Communications', type='url_citation', url='https://www.nature.com/articles/s41467-024-54324-9#:~:text=imaging%20experiments%20we%20show%20here,Rab7a%20and%20TPC2%20protein%20interaction')